Table of Contents

 

 

 

UNITED STATES
 SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 10-Q

 

(Mark One)

 

x       QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended June 30, 2017

 

OR

 

o          TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Commission file number 0-16244

 


 

VEECO INSTRUMENTS INC.

(Exact Name of Registrant as Specified in Its Charter)

 

Delaware

 

11-2989601

(State or Other Jurisdiction of Incorporation or Organization)

 

(I.R.S. Employer Identification No.)

 

 

 

Terminal Drive

 

 

Plainview, New York

 

11803

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code:

(516) 677-0200

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.                                                            Yes x     No o

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).   Yes x     No o

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

o

Accelerated filer x

 

Non-accelerated filer

o (Do not check if a smaller reporting company)

Smaller reporting company

o

 

 

 

 

 

 

Emerging growth company

o

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes o     No x

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date:

 

Title of Class

 

Shares Outstanding

Common Stock

 

as of July 26, 2017

par value $0.01 per share

 

48,420,617

 

 

 



Table of Contents

 

VEECO INSTRUMENTS INC.

 

IND EX

 

Safe Harbor Statement

1

 

 

PART I—FINANCIAL INFORMATION

3

 

 

Item 1. Financial Statements

3

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

25

 

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk

34

 

 

Item 4. Controls and Procedures

34

 

 

PART II—OTHER INFORMATION

36

 

 

Item 1. Legal Proceedings

36

 

 

Item 1A. Risk Factors

36

 

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

36

 

 

Item 3. Defaults Upon Senior Securities

36

 

 

Item 4. Mine Safety Disclosures

36

 

 

Item 5. Other Information

36

 

 

Item 6. Exhibits

37

 

 

SIGNATURES

38

 



Table of Contents

 

Safe Harbor Statement

 

This quarterly report on Form 10-Q (the “Report”) contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Discussions containing such forward-looking statements may be found in Part I - Items 1, 2, and 3 hereof, as well as within this Report generally. In addition, when used in this Report, the words “believes,” “anticipates,” “expects,” “estimates,” “targets,” “plans,” “intends,” “will,” and similar expressions related to the future are intended to identify forward-looking statements. All forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from projected results.

 

In addition, the preparation of financial statements in conformity with U.S. Generally Accepted Accounting Principles (“U.S. GAAP”) requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Although these estimates and assumptions are based on knowledge of current events and planned actions to be undertaken in the future, they may ultimately differ from actual results. Operating results for the six months ended June 30, 2017 are not necessarily indicative of the results that may be expected for the year ending December 31, 2017. All estimates and assumptions are subject to a number of risks and uncertainties that could cause actual results to differ materially from these estimates and assumptions.

 

The risks and uncertainties of Veeco Instruments Inc. (together with its consolidated subsidiaries, “Veeco,” the “Company,” “we,” “us,” and “our,” unless the context indicates otherwise) include, without limitation, the following:

 

·                   Unfavorable market conditions may adversely affect our operating results;

 

·                   A reduction or elimination of foreign government subsidies and economic incentives may adversely affect the future order rate for our MOCVD equipment;

 

·                   The cyclicality of the industries we serve directly affects our business;

 

·                   We operate in industries characterized by rapid technological change;

 

·                   We have a concentrated customer base, located primarily in a limited number of regions, which operate in highly concentrated industries;

 

·                   We face significant competition;

 

·                   The timing of our orders, shipments, and revenue recognition may cause our quarterly operating results to fluctuate significantly;

 

·                   Our sales cycle is long and unpredictable;

 

·                   Our backlog is subject to customer cancellation or modification which could result in decreased sales, increased inventory obsolescence, and/or liabilities to our suppliers for products no longer needed;

 

·                   Our failure to estimate customer demand accurately could result in inventory obsolescence, liabilities to our suppliers for products no longer needed, and/or manufacturing interruptions or delays which could affect our ability to meet customer demand;

 

·                   Our failure to successfully manage our outsourcing activities or failure of our outsourcing partners to perform as anticipated could adversely affect our results of operations and our ability to adapt to fluctuating order volumes;

 

·                   We rely on a limited number of suppliers, some of whom are our sole source for particular components;

 

·                   Our inability to attract, retain, and motivate employees could have a material adverse effect on our business;

 

·                   Our acquisition strategy subjects us to risks associated with evaluating and pursuing these opportunities and integrating these businesses;

 

·                   Timing of market adoption of LED technology for general lighting is uncertain;

 

·                   Our sales to manufacturers are highly dependent on sales of consumer electronics applications, which can experience significant volatility due to seasonal and other factors and materially adversely impact our future results of operations;

 

1



Table of Contents

 

·                   Our operating results have been, and may continue to be, adversely affected by tightening credit markets;

 

·                   We are exposed to the risks of operating a global business, including the need to obtain export licenses for certain of our shipments and political risks in the countries we operate;

 

·                   We may be exposed to liabilities under the Foreign Corrupt Practices Act and any determination that we violated these or similar laws could have a material adverse effect on our business;

 

·                   We are subject to internal control evaluations and attestation requirements of Section 404 of the Sarbanes-Oxley Act and any delays or difficulty in satisfying these requirements or negative reports concerning our internal controls could adversely affect our future results of operations and our stock price;

 

·                   Changes in accounting pronouncements or taxation rules or practices may adversely affect our financial results;

 

·                   Our income taxes can change;

 

·                   We may be required to take additional impairment charges on assets;

 

·                   We have indebtedness in the form of convertible senior notes which could adversely affect our financial position, prevent us from implementing our strategy, and dilute the ownership interest of our existing shareholders;

 

·                   The accounting method for convertible debt securities that may be settled in cash, such as the Convertible Senior Notes, could have a material effect on our reported financial results;

 

·                   The price of our common shares is volatile and could decline significantly;

 

·                   The enforcement and protection of our intellectual property rights may be expensive and/or divert our limited resources;

 

·                   We may be subject to claims of intellectual property infringement by others;

 

·                   We are subject to foreign currency exchange risks;

 

·                   If we are subject to cyber-attacks we could incur substantial costs and, if such attacks are successful, we could incur significant liabilities, reputational harm, and disruption to our operations;

 

·                   We have adopted certain measures that may have anti-takeover effects which may make an acquisition of our Company by another company more difficult;

 

·                   We are subject to risks of non-compliance with environmental, health, and safety regulations;

 

·                   Regulations related to conflict minerals will force us to incur additional expenses, may make our supply chain more complex, and may result in damage to our relationships with customers;

 

·                   We have significant operations in locations which could be materially and adversely impacted in the event of a natural disaster, an act of terrorism or other significant disruption; and

 

·                   We may not be able to successfully integrate the business of Ultratech with our own or realize the anticipated benefits of the merger.

 

Consequently, such forward looking statements and estimates should be regarded solely as the current plans and beliefs of Veeco. We do not undertake any obligation to update any forward looking statements to reflect future events or circumstances after the date of such statements.

 

2



Table of Contents

 

PART I—FINANCIAL INFORMATION

 

 

Item 1. Financial Statements

 

Veeco Instruments Inc. and Subsidiaries

Consolidated Balance Sheets

(in thousands, except share amounts)

 

 

 

June 30,

 

December 31,

 

 

 

2017

 

2016

 

 

 

(unaudited)

 

 

 

Assets

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

 

$

205,564

 

$

277,444

 

Short-term investments

 

97,086

 

66,787

 

Accounts receivable, net

 

108,349

 

58,020

 

Inventories

 

119,935

 

77,063

 

Deferred cost of sales

 

4,439

 

6,160

 

Prepaid expenses and other current assets

 

24,909

 

16,034

 

Total current assets

 

560,282

 

501,508

 

Property, plant and equipment, net

 

82,546

 

60,646

 

Intangible assets, net

 

396,097

 

58,378

 

Goodwill

 

303,160

 

114,908

 

Deferred income taxes

 

2,528

 

2,045

 

Other assets

 

25,056

 

21,047

 

Total assets

 

$

1,369,669

 

$

758,532

 

 

 

 

 

 

 

Liabilities and stockholders’ equity

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Accounts payable

 

$

46,040

 

$

22,607

 

Accrued expenses and other current liabilities

 

44,305

 

33,201

 

Customer deposits and deferred revenue

 

76,985

 

85,022

 

Income taxes payable

 

4,316

 

2,311

 

Current portion of long-term debt

 

1,013

 

368

 

Total current liabilities

 

172,659

 

143,509

 

Deferred income taxes

 

46,291

 

13,199

 

Long-term debt

 

270,071

 

826

 

Other liabilities

 

11,163

 

6,403

 

Total liabilities

 

500,184

 

163,937

 

Stockholders’ equity:

 

 

 

 

 

Preferred stock, $0.01 par value; 500,000 shares authorized; no shares issued and outstanding

 

 

 

Common stock, $0.01 par value; 120,000,000 shares authorized; 48,382,213 and 40,714,790 shares issued at June 30, 2017 and December 31, 2016, respectively; 48,382,213 and 40,588,194 shares outstanding at June 30, 2017 and December 31, 2016, respectively.

 

484

 

407

 

Additional paid-in capital

 

1,053,138

 

763,303

 

Accumulated deficit

 

(185,877

)

(168,583

)

Accumulated other comprehensive income

 

1,740

 

1,777

 

Treasury stock, at cost, 126,596 shares at December 31, 2016.

 

 

(2,309

)

Total stockholders’ equity

 

869,485

 

594,595

 

Total liabilities and stockholders’ equity

 

$

1,369,669

 

$

758,532

 

 

See accompanying Notes to the Consolidated Financial Statements.

 

3



Table of Contents

 

Veeco Instruments Inc. and Subsidiaries

Consolidated Statements of Operations

(in thousands, except per share amounts)

(unaudited)

 

 

 

Three months ended June 30,

 

Six months ended June 30,

 

 

 

2017

 

2016

 

2017

 

2016

 

Net sales

 

$

115,066

 

$

75,348

 

$

209,452

 

$

153,359

 

Cost of sales

 

76,346

 

43,909

 

136,533

 

89,964

 

Gross profit

 

38,720

 

31,439

 

72,919

 

63,395

 

Operating expenses, net:

 

 

 

 

 

 

 

 

 

Research and development

 

18,619

 

21,543

 

33,608

 

43,653

 

Selling, general, and administrative

 

22,698

 

19,995

 

41,801

 

39,834

 

Amortization of intangible assets

 

6,354

 

5,273

 

9,221

 

10,524

 

Restructuring

 

3,257

 

2,095

 

4,595

 

2,195

 

Acquisition costs

 

14,133

 

 

15,494

 

 

Asset impairment

 

675

 

13,627

 

1,138

 

13,627

 

Other, net

 

(10

)

159

 

(87

)

88

 

Total operating expenses, net

 

65,726

 

62,692

 

105,770

 

109,921

 

Operating income (loss)

 

(27,006

)

(31,253

)

(32,851

)

(46,526

)

Interest income

 

782

 

290

 

1,575

 

596

 

Interest expense

 

(5,061

)

(105

)

(9,196

)

(143

)

Income (loss) before income taxes

 

(31,285

)

(31,068

)

(40,472

)

(46,073

)

Income tax expense (benefit)

 

(12,897

)

1,014

 

(23,179

)

1,542

 

Net income (loss)

 

$

(18,388

)

$

(32,082

)

$

(17,293

)

$

(47,615

)

 

 

 

 

 

 

 

 

 

 

Income (loss) per common share:

 

 

 

 

 

 

 

 

 

Basic

 

$

(0.43

)

$

(0.82

)

$

(0.42

)

$

(1.22

)

Diluted

 

$

(0.43

)

$

(0.82

)

$

(0.42

)

$

(1.22

)

 

 

 

 

 

 

 

 

 

 

Weighted average number of shares:

 

 

 

 

 

 

 

 

 

Basic

 

42,656

 

38,965

 

41,160

 

39,035

 

Diluted

 

42,656

 

38,965

 

41,160

 

39,035

 

 

See accompanying Notes to the Consolidated Financial Statements.

 

4



Table of Contents

 

Veeco Instruments Inc. and Subsidiaries

Consolidated Statements of Comprehensive Income (Loss)

(in thousands)

(unaudited)

 

 

 

Three months ended June 30,

 

Six months ended June 30,

 

 

 

2017

 

2016

 

2017

 

2016

 

Net income (loss)

 

$

(18,388

)

$

(32,082

)

$

(17,293

)

$

(47,615

)

Other comprehensive income, net of tax

 

 

 

 

 

 

 

 

 

Unrealized gain (loss) on available-for-sale securities

 

53

 

(11

)

(61

)

39

 

Foreign currency translation

 

9

 

(12

)

24

 

27

 

Total other comprehensive income, net of tax

 

62

 

(23

)

(37

)

66

 

 

 

 

 

 

 

 

 

 

 

Comprehensive income (loss)

 

$

(18,326

)

$

(32,105

)

$

(17,330

)

$

(47,549

)

 

See accompanying Notes to the Consolidated Financial Statements.

 

5



Table of Contents

 

Veeco Instruments Inc. and Subsidiaries

Consolidated Statements of Cash Flows

(in thousands)

(unaudited)

 

 

 

Six months ended June 30,

 

 

 

2017

 

2016

 

Cash Flows from Operating Activities

 

 

 

 

 

Net income (loss)

 

$

(17,293

)

$

(47,615

)

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:

 

 

 

 

 

Depreciation and amortization

 

15,620

 

17,291

 

Non-cash interest expense

 

4,887

 

 

Deferred income taxes

 

(19,412

)

1,821

 

Share-based compensation expense

 

13,806

 

8,390

 

Asset impairment

 

1,138

 

13,627

 

Provision for bad debts

 

92

 

160

 

Changes in operating assets and liabilities:

 

 

 

 

 

Accounts receivable

 

(4,956

)

7,584

 

Inventories and deferred cost of sales

 

20,496

 

(14,577

)

Prepaid expenses and other current assets

 

608

 

2,404

 

Accounts payable and accrued expenses

 

(7,103

)

(9,156

)

Customer deposits and deferred revenue

 

(12,872

)

(10,378

)

Long-term income tax liability

 

(4,877

)

 

Other, net

 

277

 

(682

)

Net cash provided by (used in) operating activities

 

(9,589

)

(31,131

)

 

 

 

 

 

 

Cash Flows from Investing Activities

 

 

 

 

 

Acquisitions of businesses, net of cash acquired

 

(399,478

)

 

Capital expenditures

 

(10,057

)

(9,179

)

Proceeds from the sale of investments

 

235,586

 

78,145

 

Payments for purchases of investments

 

(219,141

)

(35,533

)

Other

 

 

(213

)

Net cash provided by (used in) investing activities

 

(393,090

)

33,220

 

 

 

 

 

 

 

Cash Flows from Financing Activities

 

 

 

 

 

Proceeds (tax withholdings) from stock option exercises and employee stock purchase plan

 

1,498

 

473

 

Restricted stock tax withholdings

 

(6,294

)

(665

)

Purchases of common stock

 

 

(13,349

)

Proceeds from long-term debt borrowings

 

335,751

 

 

Principal payments on long-term debt

 

(180

)

(166

)

Net cash provided by (used in) financing activities

 

330,775

 

(13,707

)

 

 

 

 

 

 

Effect of exchange rate changes on cash and cash equivalents

 

24

 

27

 

Net increase (decrease) in cash and cash equivalents

 

(71,880

)

(11,591

)

Cash and cash equivalents - beginning of period

 

277,444

 

269,232

 

Cash and cash equivalents - end of period

 

$

205,564

 

$

257,641

 

 

 

 

 

 

 

Supplemental Disclosure of Cash Flow Information

 

 

 

 

 

Interest paid

 

$

65

 

$

103

 

Income taxes paid

 

1,422

 

1,284

 

Non-cash operating and financing activities

 

 

 

 

 

Net transfer of inventory to property, plant and equipment

 

33

 

 

 

See accompanying Notes to the Consolidated Financial Statements.

 

6



Table of Contents

 

Note 1 - Basis of Presentation

 

The accompanying unaudited Consolidated Financial Statements of Veeco have been prepared in accordance with U.S. GAAP as defined in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification 270 for interim financial information and with the instructions to Rule 10-01 of Securities and Exchange Commission Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements as the interim information is an update of the information that was presented in Veeco’s most recent annual financial statements. For further information, refer to Veeco’s Consolidated Financial Statements and Notes thereto included in the Annual Report on Form 10-K for the year ended December 31, 2016 (“2016 Form 10-K”). In the opinion of management, all adjustments considered necessary for a fair presentation have been included. All such adjustments are of a normal, recurring nature. C ertain amounts previously reported have been reclassified in the financial statements to conform to the current presentation.

 

Veeco reports interim quarters on a 13-week basis ending on the last Sunday of each quarter. The fourth quarter always ends on the last day of the calendar year, December 31. The 2017 interim quarters end on April 2, July 2, and October 1, and the 2016 interim quarters ended on April 3, July 3, and October 2. These interim quarters are reported as March 31, June 30, and September 30 in Veeco’s interim consolidated financial statements.

 

Revenue recognition

 

Veeco recognizes revenue when all of the following criteria have been met: persuasive evidence of an arrangement exists with a customer; delivery of the specified products has occurred or services have been rendered; prices are contractually fixed or determinable; and collectability is reasonably assured. Revenue is recorded including shipping and handling costs and excluding applicable taxes related to sales.

 

Contracts with customers frequently contain multiple deliverables , such as systems, upgrades, components, spare parts, maintenance, and service plans . Judgment is required to properly identify the accounting units of the multiple-element arrangements and to determine how the revenue should be allocated among the accounting units. Veeco also evaluates whether multiple transactions with the same customer or related parties should be considered part of a single, multiple-element arrangement based on an assessment of whether the contracts or agreements are negotiated or executed within a short time frame of each other or if there are indicators that the contracts are negotiated in contemplation of one another. Moreover, judgment is used in interpreting the commercial terms and determining when all criteria have been met in order to recognize revenue in the appropriate accounting period.

 

When there are separate units of accounting, Veeco allocates revenue to each element based on the following selling price hierarchy: vendor-specific objective evidence (“VSOE”) if available; third party evidence (“TPE”) if VSOE is not available; or the best estimate of selling price (“BESP”) if neither VSOE nor TPE is available. Veeco uses BESP for the elements in its arrangements. The maximum revenue recognized on a delivered element is limited to the amount that is not contingent upon the delivery of additional items.

 

Veeco considers many facts when evaluating each of its sales arrangements to determine the timing of revenue recognition including its contractual obligations, the customer’s creditworthiness, and the nature of the customer’s post-delivery acceptance provisions. Veeco’s system sales arrangements, including certain upgrades, generally include field acceptance provisions that may include functional or mechanical test procedures. For the majority of the arrangements, a customer source inspection of the system is performed in Veeco’s facility or test data is sent to the customer documenting that the system is functioning to the agreed upon specifications prior to delivery. Historically, such source inspection or test data replicates the field acceptance provisions that are performed at the customer’s site prior to final acceptance of the system. When Veeco objectively demonstrates that the criteria specified in the contractual acceptance provisions are achieved prior to delivery, revenue is recognized upon system delivery since there is no substantive contingency remaining related to the acceptance provisions at that date, subject to the retention amount constraint described below for certain contracts. For new products, new applications of existing products, or for products with substantive customer acceptance provisions where Veeco cannot objectively demonstrate that the criteria specified in the contractual acceptance provisions have been achieved prior to delivery, revenue and the associated costs are deferred and fully recognized upon the receipt of final customer acceptance, assuming all other revenue recognition criteria have been met.

 

7



Table of Contents

 

The Company’s system sales arrangements, including certain upgrades, generally do not contain provisions for the right of return, forfeiture, refund, or other purchase price concession. In the rare instances where such provisions are included, all revenue is deferred until such rights expire. The sales arrangements generally include installation. The installation process is not deemed essential to the functionality of the equipment since it is not complex; it does not require significant changes to the features or capabilities of the equipment or involve constructing elaborate interfaces or connections subsequent to factory acceptance. Veeco has a demonstrated history of consistently completing installations in a timely manner and can reliably estimate the costs of such activities. Most customers engage Veeco to perform the installation services, although there are other third-party providers with sufficient knowledge who could complete these services. Based on these factors, installation is deemed to be inconsequential or perfunctory relative to the system sale as a whole, and as a result, installation service is not considered a separate element of the arrangement. As such, Veeco records the cost of the installation at the earlier of the time of revenue recognition for the system or when installation services are performed.

 

In certain cases Veeco’s products are sold with a billing retention, typically 10% of the sales price, which is billed by Veeco and payable by the customer when field acceptance provisions are completed. The amount of revenue recognized upon delivery of a system or upgrade, if any, is limited to the lower of i) the amount billed that is not contingent upon acceptance provisions or ii) the value of the arrangement consideration allocated to the delivered elements, if such sale is part of a multiple-element arrangement.

 

The Company recognizes revenue related to maintenance and service contracts ratably over the applicable contract term. Veeco recognizes revenue from the sales of components, spare parts, and specified service engagements at the time of delivery in accordance with the terms of the applicable sales arrangement.

 

Incremental direct costs incurred related to the acquisition of a customer contract, such as sales commissions, are expensed as incurred, even if the related revenue is deferred in accordance with the above policy.

 

Recent accounting pronouncements

 

The FASB issued ASU 2014-09, as amended: Revenue from Contracts with Customers , which has been codified as Accounting Standards Codification 606 (“ASC 606”). ASC 606 requires the Company’s revenue recognition to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which it expects to be entitled in exchange for those goods or services. ASC 606 outlines a five-step model to make the revenue recognition determination and requires new financial statement disclosures. Publicly-traded companies are required to adopt ASC 606 for reporting periods beginning after December 15, 2017, but can adopt early for annual periods beginning after December 15, 2016. The Company is still completing its evaluation of the impact of adopting this standard; however, the Company currently expects the most significant financial statement impacts of adopting ASC 606 will be the elimination of the constraint on revenue associated with the billing retention related to the receipt of customer final acceptance as well as the identification of installation services as a performance obligation. The elimination of the constraint on revenue related to customer final acceptance, which is usually about 10 percent of a system sale, will generally be recognized at the time the Company transfers control of the system to the customer, which is earlier than under the Company’s current revenue recognition model for certain contracts that are subject to the billing retention constraint described above. The new performance obligation related to installation services under the new standard will generally be recognized as the installation services are performed, which is later than under the Company’s current revenue recognition model. Taken together, the Company currently believes there will be a net acceleration of a small percentage of its revenue under ASC 606 as compared to its current revenue recognition model. ASC 606 provides for different transition alternatives, and the Company is evaluating which method of adoption to select.

 

In January 2016, the FASB issued ASU 2016-01: Financial Instruments — Overall , which requires certain equity investments to be measured at fair value, with changes in fair value recognized in net income. Publicly-traded companies are required to adopt the update for reporting periods beginning after December 15, 2017; early adoption is permitted. The Company does not expect this ASU will have a material impact on the consolidated financial statements.

 

In February 2016, the FASB issued ASU 2016-02: Leases , which generally requires operating lessee rights and

 

8



Table of Contents

 

obligations to be recognized as assets and liabilities on the balance sheet. In addition, interest on lease liabilities is to be recognized separately from the amortization of right-of-use assets in the Statement of Operations. Further, payments of the principal portion of lease liabilities are to be classified as financing activities while payments of interest on lease liabilities and variable lease payments are to be classified as operating activities in the Statement of Cash Flows. When the standard is adopted, the Company will be required to recognize and measure leases at the beginning of the earliest period presented using a modified retrospective approach. ASU 2016-02 is effective for fiscal years beginning after December 15, 2018, with early application permitted. The Company is evaluating the anticipated impact of adopting the ASU on the consolidated financial statements.

 

In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows: Classification of Certain Cash Receipts and Cash Payments , which provides guidance on eight specific cash flow issues, including debt prepayments or debt extinguishment costs. Publicly-traded companies are required to adopt the update for reporting periods beginning after December 15, 2017. This ASU will not have a material impact on the consolidated financial statements.

 

In October 2016, the FASB issued ASU 2016-16,  Income Taxes: Intra-Entity Transfers of Assets Other Than Inventory , which requires that entities recognize the income tax consequences of an intra-entity transfer of an asset, other than inventory, when the transfer occurs. Publicly-traded companies are required to adopt the update for reporting periods beginning after December 15, 2017. The Company is evaluating the anticipated effect the ASU will have on the consolidated financial statements.

 

The Company is also evaluating other pronouncements recently issued but not yet adopted. The adoption of these pronouncements is not expected to have a material impact on our consolidated financial statements.

 

Note 2 - Income (Loss) Per Common Share

 

The Company considers unvested share-based awards that have non-forfeitable rights to dividends prior to vesting to be participating shares, which are treated as a separate class of security from the Company’s common shares for calculating per share data. Therefore, the Company applies the two-class method when calculating income (loss) per share. The two-class method is an earnings allocation formula that determines earnings per share for each class of common stock and participating security according to dividends declared and participation rights in undistributed earnings. However, since the holders of the participating shares are not obligated to fund losses, participating shares are excluded from the calculation of loss per share.

 

The dilutive effect of the Convertible Senior Notes on income (loss) per share is calculated using the treasury stock method since the Company has both the current intent and ability to settle the principal amount of the Convertible Senior Notes in cash. See Note 5, “Liabilities,” for additional information on the Convertible Senior Notes.

 

Basic income (loss) per share is calculated by dividing net income (loss) by the weighted average number of shares outstanding during the period under the two-class method. Diluted income per share is calculated by dividing net income by the weighted average number of shares used to calculate basic income (loss) per share plus the weighted average number of common share equivalents outstanding during the period. The dilutive effect of outstanding options to purchase common stock and non-participating share-based awards is considered in diluted income per share by application of the treasury stock method. The dilutive effect of performance share units is included in diluted income per common share in the periods the performance targets have been achieved. The computations of basic and diluted income (loss) per share for the three and six months ended June 30, 2017 and 2016 are as follows:

 

9



Table of Contents

 

 

 

Three months ended June 30,

 

Six months ended June 30,

 

 

 

2017

 

2016

 

2017

 

2016

 

 

 

(in thousands, except per share amounts)

 

Net income (loss)

 

$

(18,388

)

$

(32,082

)

$

(17,293

)

$

(47,615

)

 

 

 

 

 

 

 

 

 

 

Net income (loss) per common share:

 

 

 

 

 

 

 

 

 

Basic

 

$

(0.43

)

$

(0.82

)

$

(0.42

)

$

(1.22

)

Diluted

 

$

(0.43

)

$

(0.82

)

$

(0.42

)

$

(1.22

)

 

 

 

 

 

 

 

 

 

 

Basic weighted average shares outstanding

 

42,656

 

38,965

 

41,160

 

39,035

 

Effect of potentially dilutive share-based awards

 

 

 

 

 

Diluted weighted average shares outstanding

 

42,656

 

38,965

 

41,160

 

39,035

 

 

 

 

 

 

 

 

 

 

 

Unvested participating shares excluded from basic weighted average shares outstanding since the securityholders are not obligated to fund losses

 

228

 

659

 

228

 

691

 

 

 

 

 

 

 

 

 

 

 

Common share equivalents excluded from the diluted weighted average shares outstanding since Veeco incurred a net loss and their effect would be antidilutive

 

330

 

34

 

294

 

50

 

 

 

 

 

 

 

 

 

 

 

Potentially dilutive non-participating shares excluded from the diluted calculation as their effect would be antidilutive

 

1,265

 

2,425

 

1,462

 

2,350

 

 

 

 

 

 

 

 

 

 

 

Maximum potential shares to be issued for settlement of Convertible Senior Notes excluded from the diluted calculation as their effect would be antidilutive

 

8,618

 

 

8,618

 

 

 

Note 3 — Business Combinations

 

Ultratech

 

On May 26, 2017, the Company completed its acquisition of Ultratech, Inc. (“Ultratech”).  Ultratech designs, manufactures, and markets lithography, laser annealing, and inspection equipment for manufacturers of semiconductor devices, including advanced packaging, MEMS, and atomic layer deposition (“ALD”) applications. Ultratech’s customers are primarily located throughout the United States, EMEA, China, Japan, Taiwan, and Korea. With the addition of Ultratech, the Company establishes itself as a leading equipment supplier in the advanced packaging market, forming a strong technology portfolio to address critical advanced packaging applications. The results of Ultratech’s operations have been included in the consolidated financial statements since the date of acquisition.

 

Ultratech shareholders received (i) $21.75 per share in cash and (ii) 0.2675 of a share of Veeco common stock for each Ultratech common share outstanding on the acquisition date. The Company plans to finalize the purchase accounting within the measurement period, which may include adjustments to the fair values of assets acquired and liabilities assumed. The preliminary acquisition date fair value of the consideration totaled $633.4 million, net of cash acquired, which consisted of the following:

 

 

 

Acquisition Date

 

 

 

(May 26, 2017)

 

 

 

(in thousands)

 

Amount paid, net of cash acquired

 

$

399,478

 

Fair value of equity issuances (7.4 million shares issued)

 

233,655

 

Replacement equity awards attributable to pre-acquisition service

 

228

 

Acquisition date fair value

 

$

633,361

 

 

10



Table of Contents

 

The following table summarizes the preliminary estimated fair values of the assets acquired and liabilities assumed at the acquisition date:

 

 

 

Acquisition Date

 

 

 

(May 26, 2017)

 

 

 

(in thousands)

 

Short-term investments

 

$

47,161

 

Accounts receivable

 

45,465

 

Inventory and deferred cost of sales

 

61,680

 

Prepaid expense and other current assets

 

7,217

 

Property, plant, and equipment

 

19,555

 

Intangible assets

 

346,940

 

Other assets

 

6,442

 

Total identifiable assets acquired

 

534,460

 

 

 

 

 

Accounts payable and accrued expenses

 

40,087

 

Customer deposits and deferred revenue

 

4,834

 

Deferred income taxes

 

32,478

 

Other liabilities

 

11,952

 

Total liabilities assumed

 

89,351

 

 

 

 

 

Net identifiable assets acquired

 

445,109

 

Goodwill

 

188,252

 

Net assets acquired

 

$

633,361

 

 

The gross contractual value of the acquired accounts receivable was approximately $46.0 million. The fair value of the accounts receivables is the amount expected to be collected by the Company. Goodwill generated from the acquisition is primarily attributable to expected synergies from future growth and strategic advantages provided through the expansion of product offerings as well as assembled workforce and is not expected to be deductible for income tax purposes. The Company has not yet completed its analysis of the allocation of the above acquired goodwill to the reporting units.

 

The preliminary classes of intangible assets acquired and the estimated useful life of each class is presented in the table below:

 

 

 

Acquisition Date

 

 

 

(May 26, 2017)

 

 

 

Amount

 

Useful life

 

 

 

(in thousands)

 

 

 

Technology

 

$

158,390

 

9 years

 

Customer relationships

 

116,710

 

12 years

 

Backlog

 

3,080

 

6 months

 

In-process research and development

 

43,340

 

*

 

Trademark and tradenames

 

25,420

 

7 years

 

Intangible assets acquired

 

$

346,940

 

 

 

 


*In-process research and development will be amortized (or impaired) upon completion (or abandonment) of the development project

 

The Company determined the estimated fair value of the identifiable intangible assets based on various factors including: cost, discounted cash flow, income method, loss-of-revenue/income method, and relief-from-royalty method in determining the purchase price allocation.

 

11



Table of Contents

 

In-process research and development (IPR&D) represents the estimated fair values of incomplete Ultratech research and development projects that had not reached the commercialization stage and meet the criteria for recognition as IPR&D as of the date of the acquisition. In the future, the fair value of each project at the acquisition date will be either amortized or impaired depending on whether the projects are completed or abandoned. The fair value of IPR&D was determined using an income approach, and costs to complete the project and expected commercialization timelines are considered key assumptions. This valuation approach reflects the present value of the projected cash flows that are expected to be generated by the IPR&D less charges representing the contribution of other assets to those cash flows. The value of the IPR&D was determined to be $43.3 million, approximately half of which is related to the Company’s lithography technologies and one-third of which is related to the Company’s laser annealing technologies.

 

For the three and six months ended June 30, 2017, acquisition related costs were approximately $14.1 million and $15.5 million, respectively, including non-cash charges of $4.2 million for the three months ended June 30, 2017 related to accelerated share-based compensation for employee terminations.

 

The amounts of revenue and income (loss) from continuing operations before income taxes of Ultratech included in the Company’s consolidated statement of operations from the acquisition date to the period ending June 30, 2017 are as follows:

 

 

 

Total

 

 

 

(in thousands)

 

Revenue

 

$

24,050

 

Loss from operations before income taxes

 

$

(21,445

)

 

Loss from operations before income taxes of Ultratech for the period ending June 30, 2017 of $21.4 million includes acquisition costs of $14.1 million, release of inventory fair value step-up related to purchase accounting of $7.4 million, amortization expense on intangible assets of $3.5 million, and restructuring charges of $1.2 million.

 

The following table presents unaudited pro forma financial information as if the acquisition of Ultratech had occurred on January 1, 2016:

 

 

 

Three months ended June 30,

 

Six months ended June 30,

 

 

 

2017

 

2016

 

2017

 

2016

 

 

 

(in thousands, except per share amounts)

 

Revenue

 

$

128,399

 

$

124,272

 

$

280,194

 

$

247,493

 

Loss from operations

 

(28,898

)

(54,380

)

(32,852

)

(128,860

)

Diluted earnings per share

 

$

(0.61

)

$

(1.17

)

$

(0.70

)

$

(2.78

)

 

The pro-forma results were calculated by combining the results of the Company with the stand-alone results of Ultratech for the pre-acquisition period, and adjusting for the following:

 

(i)                                    Additional amortization expense related to identified intangibles valued as part of the purchase price allocation that would have been incurred starting on January 1, 2016.

 

(ii)                                 Additional depreciation expense for the property, plant, and equipment fair value adjustments that would have been incurred starting on January 1, 2016.

 

(iii)                              All acquisition related costs incurred by the Company as well as by Ultratech pre-acquisition have been removed from their respective periods and included in the three months ended March 31, 2016, as such expenses would have been incurred in the first quarter following the acquisition.

 

(iv)                             All amortization of inventory step-up has been removed from their respective periods and recorded in the first two quarters of 2016, as such costs would have been incurred as the corresponding inventory was sold.

 

(v)                                Additional interest expense related to the Convertible Senior Notes (see Note 5, “Liabilities”) as if they had been issued on January 1, 2016.

 

12



Table of Contents

 

(vi)                             Income tax expense (benefit) was adjusted for the impact of the above adjustments for each period.

 

Note 4 - Assets

 

Investments

 

Short-term investments are generally classified as available-for-sale and reported at fair value, with unrealized gains and losses, net of tax, presented as a separate component of stockholders’ equity under the caption “Accumulated other comprehensive income” in the Consolidated Balance Sheets. These securities may include U.S. treasuries, government agency securities, corporate debt, and commercial paper, all with maturities of greater than three months when acquired. All realized gains and losses and unrealized losses resulting from declines in fair value that are other than temporary are included in “Other, net” in the Consolidated Statements of Operations.

 

Fair value is the price that would be received for an asset or the amount paid to transfer a liability in an orderly transaction between market participants. Veeco classifies certain assets based on the following fair value hierarchy:

 

Level 1:     Quoted prices in active markets that are unadjusted and accessible at the measurement date for identical, unrestricted assets or liabilities;

 

Level 2:     Quoted prices for identical assets and liabilities in markets that are not active, quoted prices for similar assets and liabilities in active markets or financial instruments for which significant inputs are observable, either directly or indirectly; and

 

Level 3:     Prices or valuations that require inputs that are both significant to the fair value measurement and unobservable.

 

A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Veeco has evaluated the estimated fair value of financial instruments using available market information and valuations as provided by third-party sources. The use of different market assumptions and/or estimation methodologies could have a significant effect on the estimated fair value amounts.

 

The following table presents the portion of Veeco’s assets that were measured at fair value on a recurring basis at June 30, 2017 and December 31, 2016:

 

 

 

Level 1

 

Level 2

 

Level 3

 

Total

 

 

 

(in thousands)

 

June 30, 2017

 

 

 

 

 

 

 

 

 

Short-term investments

 

 

 

 

 

 

 

 

 

U.S. treasuries

 

$

34,951

 

$

 

$

 

$

34,951

 

Government agency securities

 

 

62,135

 

 

62,135

 

Total

 

$

34,951

 

$

62,135

 

$

 

$

97,086

 

 

 

 

 

 

 

 

 

 

 

December 31, 2016

 

 

 

 

 

 

 

 

 

Cash equivalents

 

 

 

 

 

 

 

 

 

Corporate debt

 

$

 

$

1,501

 

$

 

$

1,501

 

Total

 

$

 

$

1,501

 

$

 

$

1,501

 

Short-term investments

 

 

 

 

 

 

 

 

 

U.S. treasuries

 

$

40,008

 

$

 

$

 

$

40,008

 

Government agency securities

 

 

10,012

 

 

10,012

 

Corporate debt

 

 

13,773

 

 

13,773

 

Commercial paper

 

 

2,994

 

 

2,994

 

Total

 

$

40,008

 

$

26,779

 

$

 

$

66,787

 

 

There were no transfers between fair value measurement levels during the three and six months ended June 30, 2017.

 

13



Table of Contents

 

At June 30, 2017 and December 31, 2016, the amortized cost and fair value of available-for-sale securities consist of:

 

 

 

 

 

Gross

 

Gross

 

 

 

 

 

Amortized

 

Unrealized

 

Unrealized

 

Estimated

 

 

 

Cost

 

Gains

 

Losses

 

Fair Value

 

 

 

(in thousands)

 

June 30, 2017

 

 

 

 

 

 

 

 

 

U.S. treasuries

 

$

34,986

 

$

 

$

(35

)

$

34,951

 

Government agency securities

 

62,181

 

 

(46

)

62,135

 

Total

 

$

97,167

 

$

 

$

(81

)

$

97,086

 

 

 

 

 

 

 

 

 

 

 

December 31, 2016

 

 

 

 

 

 

 

 

 

U.S. treasuries

 

$

40,013

 

$

 

$

(5

)

$

40,008

 

Government agency securities

 

10,020

 

 

(8

)

10,012

 

Corporate debt

 

13,780

 

 

(7

)

13,773

 

Commercial paper

 

2,994

 

 

 

2,994

 

Total

 

$

66,807

 

$

 

$

(20

)

$

66,787

 

 

Available-for-sale securities in a loss position at June 30, 2017 and December 31, 2016 consist of:

 

 

 

June 30, 2017

 

December 31, 2016

 

 

 

 

 

Gross

 

 

 

Gross

 

 

 

Estimated

 

Unrealized

 

Estimated

 

Unrealized

 

 

 

Fair Value

 

Losses

 

Fair Value

 

Losses

 

 

 

(in thousands)

 

U.S. treasuries

 

$

34,951

 

$

(35

)

$

20,002

 

$

(5

)

Government agency securities

 

62,135

 

(46

)

10,012

 

(8

)

Corporate debt

 

 

 

13,774

 

(7

)

Total

 

$

97,086

 

$

(81

)

$

43,788

 

$

(20

)

 

At June 30, 2017 and December 31, 2016, there were no short-term investments that had been in a continuous loss position for more than 12 months.

 

The contractual maturities of securities classified as available-for-sale at June 30, 2017 were as follows:

 

 

 

June 30, 2017

 

 

 

Amortized

 

Estimated

 

 

 

cost

 

fair value

 

 

 

(in thousands)

 

Due in one year or less

 

$

72,278

 

$

72,220

 

Due after one year through two years

 

24,889

 

24,866

 

Total

 

$

97,167

 

$

97,086

 

 

Actual maturities may differ from contractual maturities. Veeco may sell these securities prior to maturity based on the needs of the business. In addition, borrowers may have the right to call or prepay obligations prior to scheduled maturities.

 

There were minimal realized gains for the three and six months ended June 30, 2017 and no realized gains for the three and six months ended June 30, 2016. The cost of securities liquidated is based on specific identification.

 

14



Table of Contents

 

Accounts receivable

 

Accounts receivable is presented net of an allowance for doubtful accounts of $0.3 million at both June 30, 2017 and December 31, 2016.

 

Inventories

 

Inventories are stated at the lower of cost or net realizable value, with cost determined on a first-in, first-out basis. Inventories at June 30, 2017 and December 31, 2016 consist of the following :

 

 

 

June 30,

 

December 31,

 

 

 

2017

 

2016

 

 

 

(in thousands)

 

Materials

 

$

58,372

 

$

46,457

 

Work-in-process

 

46,498

 

25,250

 

Finished goods

 

15,065

 

5,356

 

Total

 

$

119,935

 

$

77,063

 

 

Prepaid expenses and other current assets

 

Prepaid expenses and other current assets primarily consist of supplier deposits, prepaid value-added tax, lease deposits, prepaid insurance, and prepaid licenses. Veeco had deposits with its suppliers of $7.9 million and $7.8 million at June 30, 2017 and December 31, 2016, respectively. Also included within prepaid expenses and other current assets at June 30, 2017 were assets held for sale with a carrying value of $2.3 million related to one of the Company’s properties in St. Paul, Minnesota. The Company determined that the carrying value of this property exceeded the fair value, less cost to sell, and recorded an impairment charge of approximately $0.7 million for the three and six months ended June 30, 2017.

 

Property, plant, and equipment

 

Property, plant, and equipment at June 30, 2017 and December 31, 2016 consist of the following:

 

 

 

June 30,

 

December 31,

 

 

 

2017

 

2016

 

 

 

(in thousands)

 

Land

 

$

5,669

 

$

5,669

 

Building and improvements

 

49,832

 

50,814

 

Machinery and equipment(1)

 

122,131

 

99,370

 

Leasehold improvements

 

9,486

 

3,652

 

Gross property, plant and equipment

 

187,118

 

159,505

 

Less: accumulated depreciation and amortization

 

104,572

 

98,859

 

Net property, plant, and equipment

 

$

82,546

 

$

60,646

 

 


(1) Machinery and equipment also includes software, furniture and fixtures

 

For the three and six months ended June 30, 2017, depreciation expense was $3.5 million and $6.4 million, respectively, and $3.4 million and $6.8 million for the comparable 2016 periods.

 

Goodwill

 

Goodwill represents the future economic benefits arising from assets acquired in a business combination that are not individually identified and separately recognized. The following table presents the changes in goodwill balances for the six months ended June 30, 2017:

 

15



Table of Contents

 

 

 

Gross carrying

 

Accumulated

 

 

 

 

 

amount

 

impairment

 

Net amount

 

 

 

(in thousands)

 

Balance at December 31, 2016

 

$

238,108

 

$

123,200

 

$

114,908

 

Acquisition

 

188,252

 

 

188,252

 

Balance at June 30, 2017

 

$

426,360

 

$

123,200

 

$

303,160

 

 

Intangible assets

 

Intangible assets consist of purchased technology, customer-related intangible assets, in-process research and development, trademarks (both long-lived and indefinite-lived), patents, backlog, and licenses and are initially recorded at fair value. Long-lived intangibles are amortized over their estimated useful lives in a method reflecting the pattern in which the economic benefits are consumed or amortized on a straight-line basis if such pattern cannot be reliably determined.

 

The components of purchased intangible assets were as follows:

 

 

 

June 30, 2017

 

December 31, 2016

 

 

 

 

 

Accumulated

 

 

 

 

 

Accumulated

 

 

 

 

 

Gross

 

Amortization

 

 

 

Gross

 

Amortization

 

 

 

 

 

Carrying

 

and

 

Net

 

Carrying

 

and

 

Net

 

 

 

Amount

 

Impairment

 

Amount

 

Amount

 

Impairment

 

Amount

 

 

 

(in thousands)

 

Technology

 

$

307,588

 

$

118,863

 

$

188,725

 

$

149,198

 

$

113,904

 

$

35,294

 

Customer relationships

 

164,595

 

31,971

 

132,624

 

47,885

 

28,659

 

19,226

 

In-process R&D

 

43,340

 

 

43,340

 

 

 

 

Trademarks and tradenames

 

28,010

 

2,326

 

25,684

 

2,590

 

1,948

 

642

 

Indefinite-lived trademark

 

2,900

 

 

2,900

 

2,900

 

 

2,900

 

Other

 

3,828

 

1,004

 

2,824

 

2,026

 

1,710

 

316

 

Total

 

$

550,261

 

$

154,164

 

$

396,097

 

$

204,599

 

$

146,221

 

$

58,378

 

 

Other intangible assets primarily consist of patents, backlog, and licenses.

 

Other assets

 

Veeco has an ownership interest of less than 20% in a non-marketable investment, Kateeva, Inc. (“Kateeva”). Veeco does not exert significant influence over Kateeva and therefore the investment is carried at cost. There was no change to the $21.0 million carrying value of the investment during the six months ended June 30, 2017. The investment is included in “Other assets” on the Consolidated Balance Sheet. The investment is subject to a periodic impairment review; as there are no open-market valuations, the impairment analysis requires judgment. The analysis includes assessments of Kateeva’s financial condition, the business outlook for its products and technology, its projected results and cash flow, business valuation indications from recent rounds of financing, the likelihood of obtaining subsequent rounds of financing, and the impact of equity preferences held by Veeco relative to other investors. Fair value of the investment is not estimated unless there are identified events or changes in circumstances that could have a significant adverse effect on the fair value of the investment. No such events or circumstances are present.

 

Also included within Other assets at June 30, 2017 are deferred compensation plan assets of approximately $3.1 million representing the cash surrender value of life insurance policies held by the Company related to an executive non-qualified deferred compensation plan that was assumed from Ultratech that allows qualifying executives to defer cash compensation. The related plan liability of approximately $4.4 million is included in “Other liabilities” on the Consolidated Balance Sheet.

 

16



Table of Contents

 

Note 5 - Liabilities

 

Accrued expenses and other current liabilities

 

The components of accrued expenses and other current liabilities at June 30, 2017 and December 31, 2016 consist of:

 

 

 

June 30,

 

December 31,

 

 

 

2017

 

2016

 

 

 

(in thousands)

 

Payroll and related benefits

 

$

23,016

 

$

18,780

 

Warranty

 

6,741

 

4,217

 

Professional fees

 

2,943

 

1,827

 

Installation

 

1,386

 

1,382

 

Sales, use, and other taxes

 

1,806

 

1,282

 

Restructuring liability

 

1,373

 

1,796

 

Interest

 

4,244

 

 

Other

 

2,796

 

3,917

 

Total

 

$

44,305

 

$

33,201

 

 

Warranty

 

Warranties are typically valid for one year from the date of system final acceptance, and Veeco estimates the costs that may be incurred under the warranty. Estimated warranty costs are determined by analyzing specific product and historical configuration statistics and regional warranty support costs and are affected by product failure rates, material usage, and labor costs incurred in correcting product failures during the warranty period. Unforeseen component failures or exceptional component performance can also result in changes to warranty costs. Changes in product warranty reserves for the six months ended June 30, 2017 include:

 

 

 

(in thousands)

 

Balance - December 31, 2016

 

$

4,217

 

Warranties issued

 

2,809

 

Addition from Ultratech acquisition

 

1,889

 

Consumption of reserves

 

(2,673

)

Changes in estimate

 

499

 

Balance - June 30, 2017

 

$

6,741

 

 

Restructuring accruals

 

During the six months ended June 30, 2017, additional accruals were recognized and payments made related to previous years’ restructuring initiatives. During the second and third quarters of 2016, the Company undertook restructuring activities as part of its initiative to streamline operations, enhance efficiency, and reduce costs. As a result of these actions, the Company notified approximately 50 employees of their termination from the Company. In addition, during the third quarter of 2016, the Company decided to significantly reduce future investments in its ALD technology development, which impacted approximately 25 additional employees. Over the next few quarters, the Company expects to incur additional restructuring costs of $1 million to $3 million as it finalizes all of these activities.

 

17



Table of Contents

 

 

 

Personnel

 

 

 

 

 

 

 

Severance and

 

Facility

 

 

 

 

 

Related Costs

 

Closing Costs

 

Total

 

 

 

(in thousands)

 

Balance - December 31, 2016

 

$

1,796

 

$

 

$

1,796

 

Provision

 

1,405

 

2,349

 

3,754

 

Payments

 

(2,079

)

(2,098

)

(4,177

)

Balance - June 30, 2017

 

$

1,122

 

$

251

 

$

1,373

 

 

Included within restructuring expense in the Consolidated Statements of Operations for the six months ended June 30, 2017 is approximately $0.8 million of non-cash charges related to accelerated share-based compensation for employee terminations.

 

Customer deposits

 

Customer deposits totaled $25.0 million and $22.2 million at June 30, 2017 and December 31, 2016, respectively.

 

Mortgage Payable

 

The Company has a mortgage note payable associated with its property in St. Paul, Minnesota, which, during the second quarter of 2017 was designated an asset held for sale.  The carrying value of the property exceeds the carrying value of the mortgage note, which was $1.0 million and $1.2 million at June 30, 2017 and December 31, 2016, respectively. The annual interest rate on the note is 7.91%, and the final payment is due on January 1, 2020. The Company determined the mortgage is a Level 3 liability in the fair-value hierarchy and, using a discounted cash flow model, estimated its fair value as $1.0 million and $1.2 million at June 30, 2017 and December 31, 2016, respectively.  At June 30, 2017, the remaining principle balance on the mortgage note is included in “Current portion of long-term debt” on the Consolidated Balance Sheet as the associated asset is expected to be sold within the next twelve months.

 

Convertible Senior Notes

 

On January 10, 2017, the Company issued $345.0 million of 2.70% convertible senior unsecured notes due (the “Convertible Senior Notes”). The Company received net proceeds, after deducting underwriting discounts and fees and expenses payable by the Company, of approximately $335.8 million. The Convertible Senior Notes bear interest at a rate of 2.70% per year, payable semiannually in arrears on January 15 and July 15 of each year, commencing on July 15, 2017. The Convertible Senior Notes mature on January 15, 2023, unless earlier purchased by the Company, redeemed, or converted.

 

The Convertible Senior Notes are unsecured obligations of Veeco and rank senior in right of payment to any of Veeco’s subordinated indebtedness; equal in right of payment to all of Veeco’s unsecured indebtedness that is not subordinated; effectively subordinated in right of payment to any of Veeco’s secured indebtedness to the extent of the value of the assets securing such indebtedness; and structurally subordinated to all indebtedness and other liabilities (including trade payables) of Veeco’s subsidiaries.

 

The Convertible Senior Notes are convertible into cash, shares of the Company’s common stock, or a combination thereof, at the Company’s election, upon the satisfaction of specified conditions and during certain periods as described below. The initial conversion rate is 24.9800 shares of the Company’s common stock per $1,000 principal amount of Convertible Senior Notes, representing an initial effective conversion price of $40.03 per share of common stock. The conversion rate may be subject to adjustment upon the occurrence of certain specified events as provided in the indenture governing the Convertible Senior Notes, dated January 18, 2017 between the Company and U.S. Bank National Association, as trustee (the “Indenture”), but will not be adjusted for accrued but unpaid interest.

 

Holders may convert all or any portion of their notes, in multiples of one thousand dollar principal amount, at their option at any time prior to the close of business on the business day immediately preceding October 15, 2022 only under the

 

18



Table of Contents

 

following circumstances:

 

(i)                          During any calendar quarter (and only during such calendar quarter), if the last reported sale price of the common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day;

 

(ii)                       During the five consecutive business day period after any five consecutive trading day period (the “measurement period”) in which the trading price per one thousand dollar principal amount of Convertible Senior Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of Veeco’s common stock and the conversion rate on each such trading day;

 

(iii)                    If the Company calls any or all of the Convertible Senior Notes for redemption at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or

 

(iv)                   Upon the occurrence of specified corporate events.

 

On or after October 15, 2022, until the close of business on the business day immediately preceding the Maturity Date, holders may convert their notes at any time, regardless of the foregoing circumstances.

 

Upon conversion by the holders, the Company may elect to settle such conversion in shares of its common stock, cash, or a combination thereof. As a result of its cash conversion option, the Company segregated the liability component of the instrument from the equity component. The liability component was measured by estimating the fair value of a non-convertible debt instrument that is similar in its terms to the Convertible Senior Notes. The calculation of the fair value of the debt component required the use of Level 3 inputs, including utilization of convertible investors’ credit assumptions and high yield bond indices. Fair value was estimated through discounting future interest and principal payments, an income approach, due under the Convertible Senior Notes at a discount rate of 7.00%, an interest rate equal to the estimated borrowing rate for similar non-convertible debt. The excess of the aggregate face value of the Convertible Senior Notes over the estimated fair value of the liability component of $72.5 million was recognized as a debt discount and recorded as an increase to additional paid-in capital, and will be amortized over the expected life of the Convertible Senior Notes using the effective interest rate method. Amortization of the debt discount is recognized as non-cash interest expense.

 

The transaction costs of $9.2 million incurred in connection with the issuance of the Convertible Senior Notes were allocated to the liability and equity components based on their relative values. Transaction costs allocated to the liability component are being amortized using the effective interest rate method and recognized as non-cash interest expense over the expected term of the Convertible Senior Notes. Transaction costs allocated to the equity component of $1.9 million reduced the value of the equity component recognized in stockholders’ equity.

 

The carrying value of the Convertible Senior Notes is as follows:

 

 

 

June 30,

 

 

 

2017

 

 

 

(in thousands)

 

Principal amount

 

$

345,000

 

Unamortized debt discount

 

(68,072

)

Unamortized transaction costs

 

(6,857

)

Net carrying value

 

$

270,071

 

 

Total interest expense related to the Convertible Senior Notes is as follows:

 

19



Table of Contents

 

 

 

Three months
ended June 30,

 

Six months ended
June 30,

 

 

 

2017

 

2017

 

 

 

(in thousands)

 

Cash Interest Expense

 

 

 

 

 

Coupon interest expense

 

$

2,329

 

$

4,244

 

Non-Cash Interest Expense

 

 

 

 

 

Amortization of debt discount

 

2,455

 

4,440

 

Amortization of transaction costs

 

247

 

447

 

Total Interest Expense

 

$

5,031

 

$

9,131

 

 

The Company determined the Convertible Senior Notes is a Level 2 liability in the fair value hierarchy and estimated its fair value as $354.0 million at June 30, 2017.

 

Other Liabilities

 

Other liabilities at June 30, 2017 included deferred compensation of $4.4 million, asset retirement obligations of $3.3 million, medical and dental benefits of $2.5 million, and acquisition related accruals of $1.0 million. At December 31, 2016, other liabilities primarily consisted of a non-current income tax payable of $4.9 million.

 

Note 6 - Commitments and Contingencies

 

Minimum lease commitments

 

At June 30, 2017, Veeco’s total future minimum lease payments under non-cancelable operating leases (exclusive of renewal options) are payable as follows:

 

 

 

Operating
Leases

 

 

 

(in thousands)

 

Payments due by period:

 

 

 

2017

 

$

3,528

 

2018

 

5,433

 

2019

 

4,994

 

2020

 

4,756

 

2021

 

1,799

 

Thereafter

 

4,493

 

Total

 

$

25,003

 

 

Purchase commitments

 

Veeco has purchase commitments of $144.5 million at June 30, 2017, substantially all of which become due within one year.

 

Bank guarantees

 

Veeco has bank guarantees and letters of credit issued by a financial institution on its behalf as needed. At June 30, 2017, outstanding bank guarantees and letters of credit totaled $4.1 million, and unused bank guarantees and letters of credit of $67.2 million were available to be drawn upon.

 

Legal proceedings

 

On March 17, 2017, an Ultratech shareholder filed a purported class action complaint in the U.S. District Court for the Northern District of California (the “District Court”), captioned The Vladimir Gusinsky Rev. Trust v. Ultratech, Inc., et al. ,

 

20



Table of Contents

 

Case No. 4:17-cv-01468-PJH, on behalf of itself and all other Ultratech shareholders against Ultratech, its directors at the time the acquisition was announced, Veeco, and Merger Sub.  The complaint alleges, among other things, that in connection with Veeco’s proposed acquisition of Ultratech, the defendants purportedly agreed to a supposedly inadequate price for the Ultratech shares, agreed to unreasonable deal-protection measures, and potentially engaged in supposed self-dealing.

 

On March 22, 2017, two other Ultratech shareholders filed a purported class action complaint in the District Court, captioned De Letter et al. v. Ultratech, Inc., et al. , Case No. 3:17-cv-01542-WHA, on behalf of themselves and all other Ultratech shareholders against Ultratech and its directors at the time the acquisition was announced.  The complaint alleges, among other things, that in connection with Veeco’s proposed acquisition of Ultratech, the defendants purportedly agreed to a supposedly inadequate price for the Ultratech shares and potentially engaged in supposed self-dealing.

 

On May 28, 2017, the District Court dismissed both cases.

 

Veeco is involved in various other legal proceedings arising in the normal course of business. Veeco does not believe that the ultimate resolution of these matters will have a material adverse effect on its consolidated financial position, results of operations, or cash flows.

 

Note 7 - Equity

 

Accumulated Other Comprehensive Income (“AOCI”)

 

The following table presents the changes in the balances of each component of AOCI, net of tax:

 

 

 

 

 

Unrealized

 

 

 

 

 

Foreign Currency

 

Gains (Losses) on
Available for Sale

 

 

 

 

 

Translation

 

Securities

 

Total

 

 

 

(in thousands)

 

Balance - December 31, 2016

 

$

1,797

 

$

(20

)

$

1,777

 

Other comprehensive income (loss)

 

24

 

(61

)

(37

)

Balance - June 30, 2017

 

$

1,821

 

$

(81

)

$

1,740

 

 

There were minimal reclassifications from AOCI into net income for the six months ended June 30, 2017.

 

For the six months ended June 30, 2017, Additional Paid-in Capital increased approximately $233.8 million related to 7.4 million shares issued for the Ultratech merger consideration, $49.3 million related to the issuance of the Convertible Senior Notes including deferred tax impact, and $6.7 million related to on-going share-based compensation activities.

 

Note 8 - Share-based compensation

 

Restricted share awards are issued to employees that are subject to specified restrictions and a risk of forfeiture. The restrictions typically lapse over one to five years and may entitle holders to dividends and voting rights. Other types of share-based compensation include performance share awards, performance share units, and restricted share units (collectively with restricted share awards, “restricted shares”), as well as options to purchase common stock.

 

Share-based compensation expense was recognized in the following line items in the Consolidated Statements of Operations for the three and six months ended June 30, 2017 and 2016:

 

21



Table of Contents

 

 

 

Three months ended June 30,

 

Six months ended June 30,

 

 

 

2017

 

2016

 

2017

 

2016

 

 

 

(in thousands)

 

Cost of sales

 

$

500

 

$

486

 

$

1,157

 

$

1,032

 

Research and development

 

708

 

940

 

1,137

 

2,039

 

Selling, general, and administrative

 

3,368

 

2,576

 

6,468

 

5,319

 

Restructuring

 

841

 

 

841

 

 

Acquisition costs

 

4,203

 

 

4,203

 

 

Total

 

$

9,620

 

$

4,002

 

$

13,806

 

$

8,390

 

 

For the six months ended June 30, 2017, equity activity related to stock options was as follows:

 

 

 

Number of

 

Weighted
Average

 

 

 

Shares

 

Exercise Price

 

 

 

(in thousands)

 

 

 

Balance - December 31, 2016

 

1,576

 

$

35.18

 

Granted

 

 

 

Exercised

 

(18

)

30.03

 

Expired or forfeited

 

(120

)

37.14

 

Balance - June 30, 2017

 

1,438

 

35.08

 

 

For the six months ended June 30, 2017, equity activity related to non-vested restricted shares and performance shares was as follows:

 

 

 

 

 

Weighted
Average

 

 

 

Number of

 

Grant Date

 

 

 

Shares

 

Fair Value

 

 

 

(in thousands)

 

 

 

Balance - December 31, 2016

 

1,949

 

$

23.85

 

Granted

 

649

 

29.67

 

Assumed from Ultratech

 

338

 

31.75

 

Vested

 

(549

)

25.98

 

Forfeited

 

(130

)

25.95

 

Balance - June 30, 2017

 

2,257

 

25.94

 

 

Note 9 - Income Taxes

 

Income taxes are estimated for each of the jurisdictions in which the Company operates. Deferred income taxes reflect the net tax effect of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes, as well as the tax effect of carryforwards. Realization of net deferred tax assets is dependent on future taxable income. At June 30, 2017, the Company’s U.S. deferred tax assets are fully offset by a valuation allowance since the Company cannot conclude that that it is more likely than not that these future benefits will be realized before they expire.

 

At the end of each interim reporting period, the effective tax rate is aligned to expectations for the full year. This estimate is used to determine the income tax provision on a year-to-date basis and may change in subsequent interim periods. The year-to-date tax benefit for interim period losses is limited to the amount that could be recognizable at the end of the fiscal year. Income (loss) before income taxes and income tax expense (benefit) for the three and six months ended June 30, 2017 and 2016 were as follows:

 

22



Table of Contents

 

 

 

Three months ended June 30,

 

Six months ended June 30,

 

 

 

2017

 

2016

 

2017

 

2016

 

 

 

(in thousands)

 

Loss before income taxes

 

$

(31,285

)

$

(31,068

)

$

(40,472

)

$

(46,073

)

Income tax expense (benefit)

 

$

(12,897

)

$

1,014

 

$

(23,179

)

$

1,542

 

 

The net income tax benefit for the three months ended June 30, 2017 was comprised of a net benefit of $15.4 million related to the Company’s U.S. operations, and a net tax expense of $2.5 million related to the Company’s non-U.S. operations. The net income tax benefit for the six months ended June 30, 2017 was comprised of a net benefit of $19.5 million and $3.7 million related to the Company’s U.S. and non-U.S. operations, respectively.

 

The net income tax benefit from the Company’s U.S. operations was primarily attributable to a tax benefit of $16.4 million and $21.3 million for losses incurred during the three and six months ended June 30, 2017, respectively. Under the intraperiod tax allocation rules, the deferred tax liability created upon the issuance of the Convertible Senior Notes and recorded through Additional Paid-in Capital is treated as a source of income, which enables the Company to recognize a benefit for the U.S. loss before income taxes through continuing operations during fiscal 2017. The tax benefit related to the issuance of the Convertible Senior Notes will not recur in future years. When calculating the income tax benefit for the six months ended June 30, 2017, the Company was subject to a loss limitation rule as the year-to-date ordinary loss exceeded the full-year expected ordinary loss. The tax benefit for the year-to-date ordinary loss was limited to the amount that we expect to be able to recognize for the full year. This benefit was partially offset by a deferred provision of approximately $1.0 million and $1.9 million related to tax amortization on indefinite-lived intangible assets for the three and six months ended June 30, 2017, respectively.

 

The net income tax benefit of $3.7 million for the six months ended June 30, 2017, from the Company’s non-U.S. operations was primarily attributable to the Company’s determination in the first quarter of 2017 that it was more likely than not that it will meet the requirements of an existing foreign tax incentive agreement.  As a result, the Company remeasured this uncertain tax position and recognized a $6.3 million benefit during the first quarter, which is comprised of a reversal of a $4.9 million tax liability established in previous periods and the recognition of a deferred tax benefit of $1.4 million related to certain foreign net operating losses generated in prior years that are now determined to be realizable. This benefit was partially offset by a current year tax expense of approximately $2.7 million attributed to the profitable non-U.S. operations, of which approximately $2.5 million was recorded during the three months ended June 30, 2017.

 

For the three and six months ended June 30, 2016, the Company did not provide a current tax benefit on U.S. pre-tax losses since the Company could not conclude that it is more likely than not that the benefits would be realized. The tax expense is primarily related to indefinite-lived intangible assets that are amortized for tax purposes but not for financial reporting purposes, as well as taxes attributed to the profitable non-U.S. operations. The deferred tax liability created by the tax deductible expense cannot be used to offset existing deferred tax assets.

 

Note 10 - Segment Reporting and Geographic Information

 

Veeco operates and measures its results in one operating segment and continues to do so with the integration of Ultratech’s business activities. As a result, the Company has one reportable segment: the design, development, manufacture, and support of semiconductor process equipment primarily sold to make electronic devices.

 

Veeco categorizes its revenue by the key markets into which it sells.  As a result of the acquisition of Ultratech, the Company’s four key markets are now: Lighting, Display & Power Electronics; Advanced Packaging, MEMS & RF; Scientific & Industrial, which now includes Data Storage, which was formerly a separate category; and Front-End Semiconductor, which was formerly included in the Scientific & Industrial market category.

 

Lighting, Display & Power Electronics

 

Lighting refers to Light Emitting Diode (“LED”) and semiconductor illumination sources used in various applications including, but not limited to, displays such as backlights, general lighting, automotive running lights, and head lamps.

 

23



Table of Contents

 

Display refers to LEDs used for displays and Organic Light Emitting Diode (“OLED”) displays found in outdoor display/signage applications, smartphones, wearable devices, and tablets. Power Electronics refers to semiconductor devices such as rectifiers, inverters, and converters for the control and conversion of electric power.

 

Advanced Packaging, MEMS & RF (Mobility)

 

Advanced Packaging includes a portfolio of wafer-level assembly technologies that enable the miniaturization and performance improvement of electronic products, such as smartphones, smartwatches, tablets, and laptops. Micro-Electro Mechanical Systems (“MEMS”) includes tiny mechanical devices such as sensors, switches, mirrors, and actuators embedded in semiconductor chips used in vehicles, smartphones, tablets, and games. Radio Frequency (“RF”) includes semiconductor devices that make use of radio waves (RF fields) for wireless broadcasting and/or communications.

 

Scientific & Industrial

 

Scientific refers to advanced materials research at university research institutions, industry research institutions, industry consortiums, and government research agencies. Industrial refers to large-scale product manufacturing applications including high powered lasers, data storage, and optical coatings: thin layers of material deposited on a lens or mirror that alters how light reflects and transmits.

 

Front-End Semiconductor

 

Front-End Semiconductor refers to the early steps in the process of integrated circuit fabrication where the microchips are created but still remain on the silicon wafer. This includes the photomask market, which is an opaque plate that allows light to shine through in a defined pattern for use in lithography.

 

Sales by end-market and geographic region for the three and six months ended June 30, 2017 and 2016 were as follows:

 

 

 

Three months ended June 30,

 

Six months ended June 30,

 

 

 

2017

 

2016

 

2017

 

2016

 

 

 

(in thousands)

 

Sales by end-market

 

 

 

 

 

 

 

 

 

Lighting, Display & Power Electronics

 

$

56,199

 

$

24,762

 

$

110,393

 

$

47,705

 

Advanced Packaging, MEMS & RF

 

21,426

 

17,045

 

32,983

 

40,308

 

Scientific & Industrial

 

27,033

 

31,779

 

54,209

 

62,582

 

Front-End Semiconductor

 

10,408

 

1,762

 

11,867

 

2,764

 

Total

 

$

115,066

 

$

75,348

 

$

209,452

 

$

153,359

 

Sales by geographic region

 

 

 

 

 

 

 

 

 

United States

 

$

21,245

 

$

20,734

 

$

38,533

 

$

47,446

 

China

 

26,287

 

24,582

 

66,613

 

33,383

 

EMEA(1)

 

18,002

 

14,834

 

40,069

 

42,296

 

Rest of World

 

49,532

 

15,198

 

64,237

 

30,234

 

Total

 

$

115,066

 

$

75,348

 

$

209,452

 

$

153,359

 

 


(1) EMEA consists of Europe, the Middle East, and Africa

 

For geographic reporting, sales are attributed to the location in which the customer facility is located.

 

24



Table of Contents

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

Cautionary Statement Regarding Forward Looking Statements

 

Our discussion below constitutes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. When used in this Report, the words “believes,” “anticipates,” “expects,” “estimates,” “targets,” “plans,” “intends,” “will,” and similar expressions related to the future are intended to identify forward-looking statements. All forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from projected results. You should not place undue reliance on any forward-looking statements, which speak only as of the dates they are made.

 

Executive Summary

 

On May 26, 2017, we completed the acquisition of Ultratech.  Ultratech designs, manufactures, and markets lithography, laser annealing, and inspection equipment for manufacturers of semiconductor devices, including advanced packaging, MEMS, and atomic layer deposition (“ALD”) applications. Ultratech’s customers are primarily located throughout the United States, EMEA, China, Japan, Taiwan, and Korea. The results of Ultratech’s operations have been included in the consolidated financial statements since the date of acquisition.

 

Together with Ultratech, we design, manufacture, and market semiconductor process equipment aligned to meet the demands of key global trends such as energy conservation, mobility, and connectivity. Our MOCVD, lithography, laser annealing, ion beam, and single wafer etch and clean technologies play an integral role in producing LEDs for solid-state lighting and displays and in the fabrication of advanced semiconductor devices. With equipment designed to maximize performance, yield, and cost of ownership, we hold technology leadership positions in all these served markets.

 

We categorize our revenue by the key markets into which we sell.  As a result of the acquisition of Ultratech, our four key markets are now: Lighting, Display & Power Electronics; Advanced Packaging, MEMS & RF; Scientific & Industrial, which now includes Data Storage, which was formerly a separate category; and Front-End Semiconductor, which was formerly included in the Scientific & Industrial market category.

 

Sales in the Lighting, Display & Power Electronics market were driven by the continued roll-out of MOCVD systems for the LED industry.  The largest applications for LEDs are solid state lighting, followed by TV displays. Over the past few quarters demand has increased for larger LCD TV displays, which require relatively more LEDs to backlight than smaller display sizes. We have also seen an increase in LED demand for fine-pitch digital signage. These trends have driven an increase in demand for our MOCVD equipment and build-up in our MOCVD backlog. As a result, we believe that our MOCVD shipments have the potential to be higher in the second half of the year relative to the first half of 2017. Our broad portfolio of MOCVD technologies has been developed to support the most significant industry trends, including developing mid-power LEDs, utilizing larger wafer sizes, and optimizing cost-of-ownership. Our TurboDisc ® EPIK 700 GaN MOCVD system continues to win new business for blue LEDs. Our TurboDisc K475i  AsP MOCVD system targets red-orange-yellow LEDs, laser diodes, and high-efficiency triple junction photovoltaic solar cells and continues to gain market momentum.

 

Increased sales into Advanced Packaging, MEMS & RF were driven primarily by the inclusion of Ultratech sales to Advanced Packaging customers. Sales in the Advanced Packaging, MEMS & RF markets continue to be influenced by the mobility trend and increasing functionality in mobile devices. Our versatile PSP product architecture, combined with Ultratech’s Advanced Packaging lithography tools, positions us well for a multitude of advanced packaging processes, including WLFO (wafer level fan out) and 3D TSV (thru silicon via) applications.

 

Sales from Scientific & Industrial markets were supported by shipments of AD&E systems for data storage and optical applications and by shipments of MBE systems to universities and laboratories. While equipment demand from each individual market may fluctuate quarter to quarter, the diverse customer base has historically provided a relatively stable revenue stream for the company on a combined basis.

 

25



Table of Contents

 

Results of Operations

 

For the three months ended June 30, 2017 and 2016

 

The following table presents revenue and expense line items reported in our Consolidated Statements of Operations for 2017 and 2016 and the period-over-period dollar and percentage changes for those line items. Our results of operations are reported as one business segment, represented by our single operating segment, including the Ultratech business acquired.

 

 

 

Three months ended June 30,

 

Change

 

 

 

2017

 

2016

 

Period to Period

 

 

 

(dollars in thousands)

 

Net sales

 

$

115,066

 

100%

 

$

75,348

 

100%

 

$

39,718

 

53%

 

Cost of sales

 

76,346

 

66%

 

43,909

 

58%

 

32,437

 

74%

 

Gross profit

 

38,720

 

34%

 

31,439

 

42%

 

7,281

 

23%

 

Operating expenses, net:

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

18,619

 

16%

 

21,543

 

29%

 

(2,924

)

(14)%

 

Selling, general, and administrative

 

22,698

 

20%

 

19,995

 

27%

 

2,703

 

14%

 

Amortization

 

6,354

 

6%

 

5,273

 

7%

 

1,081

 

21%

 

Restructuring

 

3,257

 

3%

 

2,095

 

3%

 

1,162

 

55%

 

Acquisition costs

 

14,133

 

12%

 

 

0%

 

14,133

 

100%

 

Asset impairment

 

675

 

1%

 

13,627

 

18%

 

(12,952

)

(95)%

 

Other, net

 

(10

)

(0)%

 

159

 

0%

 

(169

)

(106)%

 

Total operating expenses, net

 

65,726

 

57%

 

62,692

 

83%

 

3,034

 

5%

 

Operating income (loss)

 

(27,006

)

(23)%

 

(31,253

)

(41)%

 

4,247

 

(14)%

 

Interest income (expense), net

 

(4,279

)

(4)%

 

185

 

0%

 

(4,464

)

*

 

Income (loss) before income taxes

 

(31,285

)

(27)%

 

(31,068

)

(41)%

 

(217

)

1%

 

Income tax expense (benefit)

 

(12,897

)

(11)%

 

1,014

 

1%

 

(13,911

)

*

 

Net income (loss)

 

$

(18,388

)

(16)%

 

$

(32,082

)

(43)%

 

$

13,694

 

(43)%

 

 


* Not meaningful

 

Net Sales

 

The following is an analysis of sales by market and by region:

 

 

 

Three months ended June 30,

 

Change

 

 

 

2017

 

2016

 

Period to Period

 

 

 

(dollars in thousands)

Sales by market

 

 

 

 

 

 

 

 

 

 

 

 

 

Lighting, Display & Power Electronics

 

$

56,199

 

49%

 

$

24,762

 

33%

 

$

31,437

 

127%

 

Advanced Packaging, MEMS & RF

 

21,426

 

19%

 

17,045

 

23%

 

4,381

 

26%

 

Scientific & Industrial

 

27,033

 

23%

 

31,779

 

42%

 

(4,746

)

(15)%

 

Front-End Semiconductor

 

10,408

 

9%

 

1,762

 

2%

 

8,646

 

491%

 

Total

 

$

115,066

 

100%

 

$

75,348

 

100%

 

$

39,718

 

53%

 

Sales by geographic region

 

 

 

 

 

 

 

 

 

 

 

 

 

United States

 

$

21,245

 

18%

 

$

20,734

 

27%

 

$

511

 

2%

 

China

 

26,287

 

23%

 

24,582

 

33%

 

1,705

 

7%

 

EMEA

 

18,002

 

16%

 

14,834

 

20%

 

3,168

 

21%

 

Rest of World

 

49,532

 

43%

 

15,198

 

20%

 

34,334

 

226%

 

Total

 

$

115,066

 

100%

 

$

75,348

 

100%

 

$

39,718

 

53%

 

 


* Not meaningful

 

26



Table of Contents

 

Total sales increased for the three months ended June 30, 2017 against the comparable prior year period, primarily due to increased sales in Lighting, Display & Power Electronics as we continue to see ongoing improvements in LED industry conditions, as well as additional sales from the Ultratech business acquired in May 2017, spread across all markets. The increase was partially offset by decreased sales in the Scientific & Industrial markets. Pricing was not a significant driver of the change in total sales. By geography, sales increased in all geographic regions. The most significant increase occurred in the Rest of World region, which was attributable to the increased sales in the Lighting, Display & Power Electronics market, as well as additional sales from the Ultratech business acquired. We expect there will continue to be year-to-year variations in our future sales distribution across markets and geographies.

 

Orders increased to $122.7 million for the three months ended June 30, 2017 from $67.7 million for the comparable prior year period. The increase in orders was primarily attributable to an increase of over 180% in orders in Lighting, Display & Power Electronics, as well as additional bookings from the Ultratech business acquired in May 2017 largely in Advanced Packaging, MEMS, and RF.

 

One of the performance measures we use as a leading indicator of the business is the book-to-bill ratio. The ratio is defined as orders recorded in a given period divided by revenue recognized in the same period. A ratio greater than one indicates we are adding orders faster than we are recognizing revenue. For the three months ended June 30, 2017, the ratio was 1.1, compared to 0.9 for the comparable prior period. Our backlog at June 30, 2017 was $269.5 million, which was higher than the backlog at March 31, 2017 of $221.1 million. During the three months ended June 30, 2017, we recorded backlog adjustments of approximately $41.6 million relating to backlog acquired from Ultratech, as well as $0.8 million relating to orders that no longer met our bookings criteria.

 

Gross Profit

 

In the second quarter of 2017, gross profit increased compared to the second quarter of 2016 due to a sharp increase in sales volume, including the acquisition of Ultratech, partially offset by decreased gross margins. Gross margins decreased principally due to an inventory fair value step-up that was recorded in connection with the purchase accounting relating to the Ultratech acquisition, as well as product and region mix of sales in the period and the temporary impact of our manufacturing consolidation efforts.

 

Research and development

 

The markets we serve are characterized by continuous technological development and product innovation, and we invest in various research and development initiatives to maintain our competitive advantage and achieve our growth objectives. Research and development expenses decreased in the second quarter of 2017 compared to the second quarter of 2016 primarily as a result of our decision to significantly reduce investments in our Atomic Layer Deposition (“ALD”) technology, as well as decreases in other personnel-related expenses and professional fees as a result of our initiative to streamline operations, enhance efficiency, and reduce costs. These decreases were partially offset by the addition of the acquired Ultratech related research and development projects.

 

Selling, general, and administrative

 

Selling, general, and administrative expenses increased primarily due to the addition of the acquired Ultratech related selling, general and administrative costs.

 

Amortization expense

 

The increase in amortization expense is a result of the additional intangibles acquired as part of the acquisition of Ultratech, offset by the lower amortization resulting from the impairment of the ALD technology asset in the prior year as well as certain other intangible assets becoming fully amortized during 2016.

 

27



Table of Contents

 

Restructuring expense

 

During the three months ended June 30, 2017, additional accruals were recognized and payments made related to previous years’ restructuring initiatives. During the second and third quarters of 2016, we undertook restructuring activities as part of our initiative to streamline operations, enhance efficiency, and reduce costs. As a result of these actions,we notified approximately 50 employees of their termination from the Company. In addition, during the third quarter of 2016, we decided to significantly reduce future investments in our ALD technology development, which impacts approximately 25 additional employees. Finally, during the three months ended June 30, 2017, the Company incurred non-cash charges of approximately $0.8 million related to share-based compensation. Over the next few quarters, we expect to incur additional restructuring costs of $1 to $3 million as we finalize all of these activities.

 

Acquisition costs

 

Acquisition costs are non-recurring charges incurred in connection with the acquisition of the Ultratech business, which included $4.2 million on non-cash charges related to accelerated share-based compensation for employee terminations for the three months ended June 30, 2017.

 

Income Taxes

 

At the end of each interim reporting period, we estimate the effective income tax rate expected to be applicable for the full year. This estimate is used to determine the income tax provision or benefit on a year-to-date basis and may change in subsequent interim periods. The year-to-date tax benefit for interim period losses is limited to the amount that could be recognizable at the end of the fiscal year.

 

Our tax benefit for the three months ended June 30, 2017 was $ 12.9 million compared to a tax expense of $1.0 million for the comparable prior period. The 2017 tax benefit included a $15.4 million benefit relating to our domestic operations and a $2.5 million expense relating to our non-U.S. operations, compared to 2016 when our expense included $0.5 million related to domestic operations and $0.5 million related to our non-U.S. operations. The current period domestic tax benefit is primarily attributable to an income tax benefit for losses incurred during the three months ended June 30, 2017, as the deferred tax liability created by the issuance of the Convertible Senior Notes is treated as a source of income in fiscal 2017, offset by a deferred provision related to tax amortization on indefinite-lived intangible assets. The current period non-U.S. tax expense is attributable to the profitable non-U.S. operations. The tax expense for the comparable period is primarily attributable to the tax amortization of indefinite-lived intangible assets that is not available to offset U.S. deferred tax assets.

 

For the six months ended June 30, 2017 and 2016

 

The following table presents operating results as a percentage of net sales, as well as period-over-period dollar and percentage changes for those line items. Our results of operations are reported as one business segment, including the Ultratech business acquired.

 

28



Table of Contents

 

 

 

Six months ended June 30,

 

Change

 

 

 

2017

 

2016

 

Period to Period

 

 

 

(dollars in thousands)

 

Net sales

 

$

209,452

 

100%

 

$

153,359

 

100%

 

$

56,093

 

37%

 

Cost of sales

 

136,533

 

65%

 

89,964

 

59%

 

46,569

 

52%

 

Gross profit

 

72,919

 

35%

 

63,395

 

41%

 

9,524

 

15%

 

Operating expenses, net:

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

33,608

 

16%

 

43,653

 

28%

 

(10,045

)

(23)%

 

Selling, general, and administrative

 

41,801

 

20%

 

39,834

 

26%

 

1,967

 

5%

 

Amortization

 

9,221

 

4%

 

10,524

 

7%

 

(1,303

)

(12)%

 

Restructuring

 

4,595

 

2%

 

2,195

 

1%

 

2,400

 

109%

 

Acquisition costs

 

15,494

 

7%

 

 

0%

 

15,494

 

100%

 

Asset impairment

 

1,138

 

1%

 

13,627

 

9%

 

(12,489

)

(92)%

 

Other, net

 

(87

)

(0)%

 

88

 

0%

 

(175

)

(199)%

 

Total operating expenses, net

 

105,770

 

50%

 

109,921

 

72%

 

(4,151

)

(4)%

 

Operating income (loss)

 

(32,851

)

(16)%

 

(46,526

)

(30)%

 

13,675

 

*

 

Interest income (expense), net

 

(7,621

)

(4)%

 

453

 

0%

 

(8,074

)

*

 

Income (loss) before income taxes

 

(40,472

)

(19)%

 

(46,073

)

(30)%

 

5,601

 

*

 

Income tax expense (benefit)

 

(23,179

)

(11)%

 

1,542

 

1%

 

(24,721

)

*

 

Income (loss) from continuing operations

 

$

(17,293

)

(8)%

 

$

(47,615

)

(31)%

 

$

30,322

 

*

 

 


* Not Meaningful

 

Net Sales

 

The following is an analysis of sales by market and by region:

 

 

 

Six months ended June 30,

 

Change

 

 

 

2017

 

2016

 

Period to Period

 

 

 

(dollars in thousands)

 

Market Analysis

 

 

 

 

 

 

 

 

 

 

 

 

 

Lighting, Display & Power Electronics

 

$

110,393

 

52%

 

$

47,705

 

31%

 

$

62,688

 

131%

 

Advanced Packaging, MEMS & RF

 

32,983

 

16%

 

40,308

 

26%

 

(7,325

)

(18)%

 

Scientific & Industrial

 

54,209

 

26%

 

62,582

 

41%

 

(8,373

)

(13)%

 

Front-End Semiconductor

 

11,867

 

6%

 

2,764

 

2%

 

9,103

 

329%

 

Total Sales

 

$

209,452

 

100%

 

$

153,359

 

100%

 

$

56,093

 

37%

 

Regional Analysis

 

 

 

 

 

 

 

 

 

 

 

 

 

United States

 

$

38,533

 

18%

 

$

47,446

 

30%

 

$

(8,913

)

(19)%

 

China

 

66,613

 

32%

 

33,383

 

22%

 

33,230

 

100%

 

EMEA

 

40,069

 

19%

 

42,296

 

28%

 

(2,227

)

(5)%

 

Rest of World

 

64,237

 

31%

 

30,234

 

20%

 

34,003

 

112%

 

Total Sales

 

$

209,452

 

100%

 

$

153,359

 

100%

 

$

56,093

 

37%

 

 

Total sales increased for the six months ended June 30, 2017 against the comparable prior year period, primarily due to increased sales in Lighting, Display & Power Electronics as we continue to see ongoing improvements in LED industry conditions. The increase was partially offset by decreased sales in the Advanced Packaging, MEMS & RF and Scientific & Industrial markets. Pricing was not a significant driver of the change in total sales. By geography, sales increased in China and Rest of World, which was attributable to the increased sales in the Lighting, Display & Power Electronics market, as well as additional sales from the Ultratech business acquired in May 2017. This increase was partially offset by decreases in the other geographic regions. We expect there will continue to be year-to-year variations in our future sales distribution across markets and geographies.

 

29



Table of Contents

 

Orders increased to $230.0 million for the six months ended June 30, 2017 from $129.3 million for the comparable prior year period. The increase in orders was primarily attributable to an increase of over 170% in orders in Lighting, Display & Power Electronics, as well as a 49% increase in the Advanced Packaging, MEMS, and RF market primarily related to the Ultratech business acquired.

 

One of the performance measures we use as a leading indicator of the business is the book-to-bill ratio. The ratio is defined as orders recorded in a given period divided by revenue recognized in the same period. A ratio greater than one indicates we are adding orders faster than we are recognizing revenue. For the six months ended June 30, 2017, the ratio was 1.1, compared to 0.8 for the comparable prior period. Our backlog at June 30, 2017 was $269.5 million, which was higher than the backlog at December 31, 2016 of $209.2 million. During the six months ended June 30, 2017, we recorded backlog adjustments of approximately $41.6 million relating to backlog acquired from Ultratech, as well as $1.6 million relating to orders that no longer met our bookings criteria.

 

Gross Profit

 

For the six months ended June 30, 2017, gross profit increased compared to 2016 due to a sharp increase in sales volume, including the addition of the Ultratech business acquired in May 2017, partially offset by decreased gross margins. Gross margins decreased principally due to an inventory fair value step-up that was recorded in connection with the purchase accounting relating to the Ultratech acquisition.

 

Research and development

 

The markets we serve are characterized by continuous technological development and product innovation, and we invest in various research and development initiatives to maintain our competitive advantage and achieve our growth objectives. Research and development expenses decreased for the six months ended June 30, 2017 compared to 2016 primarily as a result of our decision to significantly reduce investments in our Atomic Layer Deposition (“ALD”) technology, as well as decreases in other personnel-related expenses and professional fees as a result of our initiative to streamline operations, enhance efficiency, and reduce costs. These decreases were partially offset by the addition of the acquired Ultratech related research and development projects.

 

Selling, general, and administrative

 

Selling, general, and administrative expenses increased for the six months ended June 30, 2017 compared to 2016 primarily due to the addition of the acquired Ultratech related selling, general and administrative costs, partially offset by a decrease in personnel-related expenses as a result of our initiative to streamline operations, enhance efficiency, and reduce costs.

 

Amortization expense

 

The slight decrease in amortization expense is a result of the impairment of the ALD technology asset in the prior year as well as certain other intangible assets becoming fully amortized during 2016, offset by increased amortization expense related to the additional intangibles acquired as part of the Ultratech business acquisition.

 

Restructuring expense

 

During the three months ended June 30, 2017, additional accruals were recognized and payments made related to previous years’ restructuring initiatives. During the second and third quarters of 2016, we undertook restructuring activities as part of our initiative to streamline operations, enhance efficiency, and reduce costs. As a result of these actions, we notified approximately 50 employees of their termination from the Company. In addition, during the third quarter of 2016, we decided to significantly reduce future investments in our ALD technology development, which impacts approximately 25 additional employees. Finally, during the three months ended June 30, 2017, the Company incurred non-cash charges of approximately $0.8 million related to share-based compensation. Over the next few quarters, we expect to incur additional restructuring costs of $1 to $3 million as we finalize all of these activities.

 

30



Table of Contents

 

Acquisition costs

 

Acquisition costs are non-recurring charges incurred in connection with the acquisition of the Ultratech business, which included $4.2 million on non-cash charges related to accelerated share-based compensation for employee terminations for the six months ended June 30, 2017.

 

Income Taxes

 

At the end of each interim reporting period, we estimate the effective income tax rate expected to be applicable for the full year. This estimate is used to determine the income tax provision or benefit on a year-to-date basis and may change in subsequent interim periods. The year-to-date tax benefit for interim period losses is limited to the amount that could be recognizable at the end of the fiscal year.

 

Our tax benefit for the six months ended June 30, 2017 was $23.2 million compared to a tax expense of $1.5 million for the comparable prior period. The 2017 tax benefit included $19.5 million relating to our domestic operations and $3.7 million relating to our non-U.S. operations, compared to 2016 when our expense included $0.9 million related to domestic operations and $0.6 million related to our non-U.S. operations. The current period domestic tax benefit is primarily attributable to an income tax benefit for losses incurred during the six months ended June 30, 2017, as the deferred tax liability created by the issuance of the Convertible Senior Notes is treated as a source of income in fiscal 2017, offset by a deferred provision related to tax amortization on indefinite-lived intangible assets. The current period non-U.S. tax benefit is primarily attributable to the remeasurement of an uncertain tax position, which included the reversal of a previously established non-U.S. tax liability and the recognition of a deferred tax benefit related to certain foreign net operating losses generated in prior years that are now determined to be realizable, offset by tax expense attributed to the profitable non-U.S. operations. The tax expense for the comparable period is primarily attributable to the tax amortization of indefinite-lived intangible assets that is not available to offset U.S. deferred tax assets.

 

Liquidity and Capital Resources

 

Our cash and cash equivalents, short-term investments, and restricted cash are as follows:

 

 

 

June 30,

 

December 31,

 

 

 

2017

 

2016

 

 

 

(in thousands)

 

Cash and cash equivalents

 

$

205,564

 

$

277,444

 

Short-term investments

 

97,086

 

66,787

 

Total

 

$

302,650

 

$

344,231

 

 

A portion of our cash and cash equivalents is held by our subsidiaries throughout the world, frequently in each subsidiary’s respective functional currency, which is typically the U.S. dollar. At June 30, 2017 and December 31, 2016, cash and cash equivalents of $152.2 million and $149.2 million, respectively, were held outside the United States. In order to fund continued international growth, it is our current intention to permanently reinvest the cash and cash equivalent balances held in China, Taiwan, and Malaysia, and our current forecasts do not require repatriation of these funds back to the United States. At June 30, 2017, we had $134.0 million in cash held outside the United States on which we may have to pay significant U.S. income taxes to repatriate or utilize net operating loss carryforwards. Additionally, local government regulations may restrict our ability to move cash balances under certain circumstances. We currently do not expect such regulations and restrictions to impact our ability to make acquisitions, pay vendors, or conduct operations. We believe that our projected cash flow from operations, combined with our cash and short term investments, will be sufficient to meet our projected working capital requirements, contractual obligations, and other cash flow needs for the next twelve months, including the scheduled interest payments on our Convertible Senior Notes issued in January 2017.

 

A summary of the cash flow activity at June 30, 2017 and December 31, 2016 is as follows:

 

31



Table of Contents

 

Cash Flows from Operating Activities

 

 

 

Six months ended June 30,

 

 

 

2017

 

2016

 

 

 

(in thousands)

 

Net income (loss)

 

$

(17,293

)

$

(47,615

)

Non-cash items:

 

 

 

 

 

Depreciation and amortization

 

15,620

 

17,291

 

Non-cash interest expense

 

4,887

 

 

Deferred income taxes

 

(19,412

)

1,821

 

Share-based compensation expense

 

13,806

 

8,390

 

Asset impairment

 

1,138

 

13,627

 

Provision for bad debts

 

92

 

160

 

Changes in operating assets and liabilities

 

(8,427

)

(24,805

)

Net cash provided by (used in) operating activities

 

$

(9,589

)

$

(31,131

)

 

Net cash used in operating activities was $9.6 million for the six months ended June 30, 2017 and was due to the net loss of $17.3 million plus adjustments for non-cash items of $16.1 million, offset by a decrease in cash flow from operating activities due to changes in operating assets and liabilities of $8.4 million.

 

Cash Flows from Investing Activities

 

 

 

Six months ended June 30,

 

 

 

2017

 

2016

 

 

 

(in thousands)

 

Acquisitions of businesses, net of cash acquired

 

$

(399,478

)

$

 

Capital expenditures

 

(10,057

)

(9,179

)

Changes in investments, net

 

16,445

 

42,612

 

Other

 

 

(213

)

Net cash provided by (used in) investing activities

 

$

(393,090

)

$

33,220

 

 

The net cash used in investing activities during the six months ended June 30, 2017 was primarily attributable to the net cash used in the acquisition of Ultratech as well as capital expenditures. As part of our efforts to streamline operations, enhance efficiency, and reduce costs, we are making certain investments in our facilities to support the consolidation activities, and, in 2017, we expect to incur future capital expenditures related to these activities of approximately $5 million to $10 million.

 

Cash Flows from Financing Activities

 

 

 

Six months ended June 30,

 

 

 

2017

 

2016

 

 

 

(in thousands)

 

Settlement of equity awards, net of withholding taxes

 

$

(4,796

)

$

(192

)

Purchases of common stock

 

 

(13,349

)

Proceeds from long-term debt borrowings

 

335,751

 

 

Repayments of long-term debt

 

(180

)

(166

)

Net cash provided by (used in) financing activities

 

$

330,775

 

$

(13,707

)

 

The cash provided by financing activities for the six months ended June 30, 2017 was primarily related to the net cash proceeds received from the issuance of the Convertible Senior Notes in January 2017. The cash used in financing activities for the six months ended June 30, 2016 was primarily related to the share repurchase program, which commenced in November 2015. There were no share repurchases in 2017.

 

32



Table of Contents

 

Convertible Senior Notes

 

On January 10, 2017, we issued $345.0 million of 2.70% convertible senior unsecured notes due (the “Convertible Senior Notes”). We received net proceeds, after deducting underwriting discounts and fees and expenses payable by the Company, of approximately $335.8 million. The Convertible Senior Notes bear interest at a rate of 2.70% per year, payable semiannually in arrears on January 15 and July 15 of each year, commencing on July 15, 2017. The Convertible Senior Notes mature on January 15, 2023, unless earlier purchased by the Company, redeemed, or converted. We believe that we have sufficient capital resources and cash flows from operations to support scheduled interest payments on this debt.

 

Business Combination

 

As discussed above, on May 26, 2017, the Company acquired 100% of Ultratech, Inc., a leading supplier of lithography, laser-processing, and inspection systems used to manufacture semiconductor devices and LEDs. The results of Ultratech’s operations have been included in the consolidated financial statements since the date of acquisition.

 

Contractual Obligations and Commitments

 

We have commitments under certain contractual arrangements to make future payments for goods and services. These contractual arrangements secure the rights to various assets and services to be used in the future in the normal course of business. We expect to fund these contractual arrangements with cash generated from operations in the normal course of business.

 

Off-Balance Sheet Arrangements

 

We do not have any off-balance sheet arrangements that have, or are reasonably likely to have, a current or future material effect on our financial condition, changes in financial condition, expenses, and results of operations, liquidity, capital expenditures or capital resources other than operating leases, bank guarantees, and purchase commitments disclosed in the preceding footnotes.

 

33



Table of Contents

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk

 

Interest Rate Risk

 

Our exposure to market rate risk for changes in interest rates primarily relates to our investment portfolio. We centrally manage our investment portfolios considering investment opportunities and risks, tax consequences, and overall financing strategies. Our investment portfolio includes fixed-income securities with a fair value of approximately $97.1 million at June 30, 2017. These securities are subject to interest rate risk and, based on our investment portfolio at June 30, 2017, a 100 basis point increase in interest rates would result in a decrease in the fair value of the portfolio of $0.6 million. While an increase in interest rates may reduce the fair value of the investment portfolio, we will not realize the losses in the Consolidated Statements of Operations unless the individual fixed-income securities are sold prior to recovery or the loss is determined to be other-than-temporary.

 

Currency Exchange Risk

 

We conduct business on a worldwide basis and, as such, a portion of our revenues, earnings, and net investments in foreign affiliates is exposed to changes in currency exchange rates. The economic impact of currency exchange rate movements is complex because such changes are often linked to variability in real growth, inflation, interest rates, governmental actions, and other factors. These changes, if material, could cause us to adjust our financing and operating strategies. Consequently, isolating the effect of changes in currency does not incorporate these other important economic factors.

 

We have managed our risks and exposures to currency exchange rates through the use of derivative financial instruments (e.g., forward contracts). We mainly use derivative financial instruments in the context of hedging and generally do not use them for speculative purposes. During the second quarter of 2017, we did not designate foreign exchange derivatives as hedges, consistent with 2016. Accordingly, all foreign exchange derivatives, if any, are recorded in our Consolidated Balance Sheet at fair value and changes in fair value from these contracts are recorded in “Other, net” in our Consolidated Statements of Operations.

 

Our net sales to customers located outside of the United States represented approximately 82% of our total net sales for the three and six months ended June 30, 2016, respectively and 73% and 70% for the comparable 2016 periods.  We expect that net sales to customers outside the United States will continue to represent a large percentage of our total net sales. Our sales denominated in currencies other than the U.S. dollar represented 2% and 3% of total net sales in the three and six months ended June 30, 2017, respectively, and 3% and 4% for the comparable 2016 periods.

 

A 10% change in foreign exchange rates would have an immaterial impact on the consolidated results of operations since most of our sales outside the United States are denominated in U.S. dollars.

 

Item 4. Controls and Procedures

 

Management’s Report on Internal Control Over Financial Reporting

 

Our principal executive and financial officers have evaluated and concluded that our disclosure controls and procedures are effective as of June 30, 2017. The disclosure controls and procedures are designed to ensure that the information required to be disclosed in this report filed under the Securities Exchange Act of 1934 is recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and is accumulated and communicated to our principal executive and financial officers as appropriate to allow timely decisions regarding required disclosure.

 

Changes in Internal Control Over Financial Reporting

 

On May 26, 2017, we completed the acquisition of Ultratech, Inc., and are integrating the acquired business into our overall internal control over financial reporting process. Management is in the process of assessing the internal control over financial reporting and is implementing or revising internal controls where necessary. See Note 3 to the Condensed Consolidated

 

34



Table of Contents

 

Financial Statements — Business Combinations , for further details. There were no other changes in internal control for the quarter ended June 30, 2017 that have materially affected or are reasonably likely to materially affect internal control over financial reporting.

 

35



Table of Contents

 

PART II—OTHER INFORMATION

 

Item 1. Legal Proceedings

 

On March 17, 2017, an Ultratech shareholder filed a purported class action complaint in the U.S. District Court for the Northern District of California (the “District Court”), captioned The Vladimir Gusinsky Rev. Trust v. Ultratech, Inc., et al. , Case No. 4:17-cv-01468-PJH, on behalf of itself and all other Ultratech shareholders against Ultratech, its directors at the time the acquisition was announced, Veeco, and Merger Sub.  The complaint alleges, among other things, that in connection with Veeco’s proposed acquisition of Ultratech, the defendants purportedly agreed to a supposedly inadequate price for the Ultratech shares, agreed to unreasonable deal-protection measures, and potentially engaged in supposed self-dealing.

 

On March 22, 2017, two other Ultratech shareholders filed a purported class action complaint in the District Court, captioned De Letter et al. v. Ultratech, Inc., et al. , Case No. 3:17-cv-01542-WHA, on behalf of themselves and all other Ultratech shareholders against Ultratech and its directors at the time the acquisition was announced.  The complaint alleges, among other things, that in connection with Veeco’s proposed acquisition of Ultratech, the defendants purportedly agreed to a supposedly inadequate price for the Ultratech shares and potentially engaged in supposed self-dealing.

 

On May 28, 2017, the District Court dismissed both cases.

 

Veeco is involved in various other legal proceedings arising in the normal course of business. Veeco does not believe that the ultimate resolution of these matters will have a material adverse effect on its consolidated financial position, results of operations, or cash flows.

 

Item 1A. Risk Factors

 

Information regarding risk factors appears in the Safe Harbor Statement at the beginning of this quarterly report on Form 10-Q and in Part I — Item 1A of our 2016 Form 10-K . There have been no material changes from the risk factors previously disclosed in our 2016 Form 10-K.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

On October 28, 2015, our Board of Directors authorized a program to repurchase up to $100 million of our common stock to be completed through October 28, 2017. At June 30, 2017, $22.3 million of the $100 million had been utilized. No repurchases occurred after the first quarter of 2016. Repurchases may be made from time to time on the open market or in privately negotiated transactions in accordance with applicable federal securities laws. The timing and amount of future repurchases, if any, will depend upon market conditions, SEC regulations, and other factors. The repurchases would be funded using available cash balances and cash generated from operations. The program does not obligate us to acquire any particular amount of common stock and may be modified or suspended at any time at our discretion.

 

Item 3. Defaults Upon Senior Securities

 

None.

 

Item 4. Mine Safety Disclosures

 

Not Applicable.

 

Item 5. Other Information

 

None.

 

36



Table of Contents

 

Item 6. Exhibits

 

Unless otherwise indicated, each of the following exhibits has been filed with the Securities and Exchange Commission by Veeco under File No. 0-16244.

 

 

 

 

 

 

 

 

 

 

 

Filed or

Exhibit

 

 

 

Incorporated by Reference

 

Furnished

Number

 

Exhibit Description

 

Form

 

Exhibit

 

Filing Date

 

Herewith

10.1

 

Amendment dated June 12, 2017 to Employment Agreement between Veeco and John R. Peeler.

 

 

 

 

 

 

 

*

10.2

 

Form of Amended and Restated Indemnification Agreement entered into between Veeco and each of its directors and executive officers, (August 2017).

 

 

 

 

 

 

 

*

10.3

 

Ultratech, Inc. 1993 Stock Option/Stock Issuance Plan (as Amended and Restated as of May 31, 2011).

 

S-8

 

4.6

 

5/26/2017

 

 

31.1

 

Certification of Chief Executive Officer pursuant to Rule 13a—14(a) or Rule 15d—14(a) of the Securities and Exchange Act of 1934.

 

 

 

 

 

 

 

*

31.2

 

Certification of Chief Financial Officer pursuant to Rule 13a—14(a) or Rule 15d—14(a) of the Securities and Exchange Act of 1934.

 

 

 

 

 

 

 

*

32.1

 

Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes - Oxley Act of 2002.

 

 

 

 

 

 

 

*

32.2

 

Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes - Oxley Act of 2002.

 

 

 

 

 

 

 

*

101.INS

 

XBRL Instance.

 

 

 

 

 

 

 

**

101.XSD

 

XBRL Schema.

 

 

 

 

 

 

 

**

101.PRE

 

XBRL Presentation.

 

 

 

 

 

 

 

**

101.CAL

 

XBRL Calculation.

 

 

 

 

 

 

 

**

101.DEF

 

XBRL Definition.

 

 

 

 

 

 

 

**

101.LAB

 

XBRL Label.

 

 

 

 

 

 

 

**

 


*                 Filed herewith

**               Filed herewith electronically

 

37



Table of Contents

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on August 3, 2017.

 

 

Veeco Instruments Inc.

 

 

 

By:

/S/ JOHN R. PEELER

 

 

John R. Peeler

 

 

Chairman and Chief Executive Officer

 

 

 

 

By:

/s/ SHUBHAM MAHESHWARI

 

 

Shubham Maheshwari

 

 

Executive Vice President and Chief Financial Officer

 

38


Exhibit 10.1

 

AMENDMENT TO

EMPLOYMENT AGREEMENT

 

THIS AMENDMENT TO EMPLOYMENT AGREEMENT dated as of June 12, 2017 by and between Veeco Instruments Inc. and John R. Peeler.

 

The parties wish to amend the Employment Agreement effective June 12, 2017, as amended June 12, 2014, June 12, 2008, December 31, 2008, June 11, 2010, April 25, 2012 and July 24, 2013 (the “Agreement”).

 

The parties herby agree as follows:

 

1.               The Company’s agreement to reimburse the reasonable housing expenses for Mr. Peeler in the Plainview, New York area and his transportation expenses to/from the Plainview area from/to his home in Maryland, including tax gross-up for these amounts, shall be amended as follows:

 

a)              Such reimbursement shall continue to be payable through June 12, 2020, provided that Mr. Peeler continues to serve in good standing as Chairman and Chief Executive Officer of the Company.

 

b)              Such reimbursement shall not be eligible for a reimbursement payment for tax gross-ups.

 

c)               Such amounts shall not exceed $75,000 per year.

 

2.               Except as amended herby, the Agreement shall continue in accordance with its terms.

 

The parties have executed this Amendment as of the date first above written.

 

VEECO INSTRUMENTS INC.

 

EXECUTIVE

 

 

 

 

 

 

By:

/s/ Gordon Hunter

 

/s/ John R. Peeler

Name: Gordon Hunter

 

John R. Peeler

Chairman of the Compensation Committee

 

 

 


Exhibit 10.2

 

AMENDED AND RESTATED

INDEMNIFICATION AGREEMENT

 

This Indemnification Agreement, dated as of                    ,         is made by and between Veeco Instruments Inc., a Delaware corporation (the “Corporation”) and                                                                                             (“Indemnitee”).

 

The Corporation recognizes that competent and experienced persons are increasingly reluctant to serve or to continue to serve as directors or officers of corporations unless they are protected by comprehensive liability insurance or indemnification, or both, due to increased exposure to litigation costs and risks resulting from their service to such corporations, and due to the fact  that the exposure frequently bears no reasonable relationship to the compensation of such directors and officers;

 

The Corporation’s Certificate of Incorporation requires the Corporation to indemnify its directors and officers to the fullest extent permitted by the Delaware General Corporation Law (the “DGCL”);

 

Section 145 of the DGCL (“Section 145”), under which the Corporation is organized, empowers the Corporation to indemnify its officers, directors, employees and agents by agreement and to indemnify persons who serve, at the request of the Corporation, as the directors, officers, employees or agents of other corporations or enterprises, and expressly provides that the indemnification provided by Section 145 is not exclusive;

 

Section 145 empowers the Corporation to pay expenses (including attorneys’ fees) incurred by its officers, directors, employees and agents by agreement or by persons who serve, at the request of the Corporation, as the directors, officers, employees or agents of other corporations or enterprises in defending proceeding in advance of the proceeding’s final disposition;

 

Section 102(b)(7) of the DGCL allows a corporation to include in its certificate of incorporation a provision limiting or eliminating the personal liability of a director for monetary damages in respect of claims by shareholders and corporations for breach of certain fiduciary duties, and the Corporation has so provided in its Certificate of Incorporation that each Director shall be exculpated from such liability to the maximum extent permitted by law;

 

The Board of Directors has determined that contractual indemnification and advancement as set forth herein is not only reasonable and prudent but also promotes the best interests of the Corporation and its stockholders; and

 

The Corporation desires and has requested Indemnitee to serve or continue to serve as a director or officer of the Corporation free from undue concern for unwarranted claims for damages arising out of or related to such services to the Corporation, which may impair the free exercise of Indemnitee’s best business judgment on behalf of the Corporation.

 

NOW, THEREFORE, in consideration of the mutual covenants and agreements set forth below, and other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the parties hereto, intending to be legally bound, hereby agree as follows:

 

1. Generally .

 

To the fullest extent permitted by the laws of the State of Delaware:

 



 

(a)                                  The Corporation shall indemnify Indemnitee if Indemnitee was or is a party to, or is involved (as a party, witness or otherwise) in, any proceeding by reason of (or arising in part out of) the fact that Indemnitee is or was or has agreed to serve at the request of the Corporation as a director, officer, employee or agent of the Corporation, or is or was serving or has agreed to serve at the request of the Corporation as a director, officer, employee or agent (which, for purposes hereof, shall include a trustee, partner or manager or similar capacity) of another corporation, partnership, joint venture, trust, employee benefit plan or other enterprise, or by reason of any action alleged to have been taken or omitted in such capacity.  For the avoidance of doubt, the foregoing indemnification obligation includes, without limitation, claims for monetary damages against Indemnitee in respect of an alleged breach of fiduciary duties, to the fullest extent permitted under Section 102(b)(7) of the DGCL as in existence on the date hereof.

 

(b)                                  The indemnification provided by this Section 1 shall be from and against expenses (including attorneys’ fees), liabilities, losses, judgments, fines, penalties and amounts paid in settlement, and any interest, assessments or other charges imposed thereon, and any federal, state, local or foreign taxes imposed on Indemnitee as a result of the actual or deemed receipt of any payments under this Agreement (collectively, “losses”) actually and reasonably incurred by Indemnitee or on Indemnitee’s behalf in connection with such proceeding and any appeal therefrom to the fullest extent permitted by Delaware law.

 

(c)                                   Notwithstanding the foregoing provisions of this Section 1, in the case of any proceeding by or in the right of the Corporation to procure a judgment in its favor by reason of the fact that Indemnitee is or was a director, officer, employee or agent of the Corporation, or is or was serving or has agreed to serve at the request of the Corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust, employee benefit plan or other enterprise, no indemnification shall be made in respect of any claim, issue or matter as to which Indemnitee shall have been adjudged to be liable to the Corporation unless, and only to the extent that, the Delaware Court of Chancery or the court in which such proceeding was brought shall determine upon application that, despite the adjudication of liability but in view of all the circumstances of the case, Indemnitee is fairly and reasonably entitled to indemnity for such amounts that the Delaware Court of Chancery or such other court shall deem proper.

 

(d)                                  The termination of any proceeding by judgment, order, settlement (whether with or without court approval) or conviction, or upon a plea of nolo contendere or its equivalent, shall not, of itself, create a presumption that Indemnitee did not act in good faith and in a manner which Indemnitee reasonably believed to be in or not opposed to the best interests of the Corporation, and, with respect to any criminal proceeding, had reasonable cause to believe that Indemnitee’s conduct was unlawful.

 

(e)                                   To the extent that Indemnitee is, by reason of Indemnitee’s current or former corporate status with respect to the Corporation or any corporation, partnership, joint venture, trust, employee benefit plan or other enterprise that Indemnitee is or was serving or has agreed to serve at the request of the Corporation, a witness or otherwise participates in any proceeding at a time when Indemnitee is not a party in the proceeding, the Corporation shall indemnify Indemnitee against all expenses (including attorneys’ fees) actually and reasonably incurred by Indemnitee or on Indemnitee’s behalf in connection therewith.

 

2



 

2. Successful Defense; Partial Indemnification .

 

(a)                                  To the extent that Indemnitee has been successful on the merits or otherwise in defense of any proceeding referred to in Section 1 hereof or in defense of any claim, issue or matter therein, Indemnitee shall be indemnified against expenses (including attorneys’ fees) actually and reasonably incurred in connection therewith.  For purposes of this Agreement and without limiting the foregoing, if any proceeding is disposed of, on the merits or otherwise (including a disposition without prejudice), without (i) the disposition being adverse to Indemnitee, (ii) an adjudication that Indemnitee was liable to the Corporation, (iii) a plea of guilty or nolo contendere by Indemnitee, (iv) an adjudication that Indemnitee did not act in good faith and in a manner Indemnitee reasonably believed to be in or not opposed to the best interests of the Corporation, and (v) with respect to any criminal proceeding, an adjudication that Indemnitee had reasonable cause to believe Indemnitee’s conduct was unlawful, Indemnitee shall be considered for the purposes hereof to have been wholly successful with respect thereto.

 

(b)                                  If Indemnitee is entitled under any provision of this Agreement to indemnification by the Corporation for some or a portion of the expenses (including attorneys’ fees) or losses actually and reasonably incurred by Indemnitee or on Indemnitee’s behalf in connection with any proceeding or investigation, or in defense of any claim, issue or matter therein, and any appeal therefrom but not, however, for the total amount thereof, the Corporation shall nevertheless indemnify Indemnitee for the portion of such expenses (including attorneys’ fees) or losses to which Indemnitee is entitled.

 

3. Advance Payment of Expenses; Notification and Defense of Claim .

 

(a)                                  To the fullest extent permitted by the laws of the State of Delaware, the Corporation shall pay, in advance of the final disposition of any proceeding, expenses (including attorneys’ fees) incurred by Indemnitee (i) in defending a threatened or pending proceeding or (ii) in acting as a witness or otherwise participating in any proceeding at a time when Indemnitee is not a party in the proceeding, by reason of Indemnitee’s current or former corporate status with respect to the Corporation or any corporation, partnership, joint venture, trust, employee benefit plan or other enterprise that Indemnitee is or was serving or has agreed to serve at the request of the Corporation.

 

(b)                                  The Corporation shall advance payment for such expenses within thirty (30) days after receipt by the Corporation of (i) a statement or statements from Indemnitee requesting such advance or advances from time to time, and (ii) an undertaking by or on behalf of Indemnitee to repay such amount or amounts advanced only if, and to the extent that, it shall ultimately be determined that Indemnitee is not entitled to be indemnified by the Corporation as authorized by this Agreement or otherwise; provided that the Corporation shall make advances only to the extent permitted by law.  Advances shall be unsecured and interest-free.

 

(c)                                   Promptly after receipt by Indemnitee of notice of the commencement of any proceeding, Indemnitee shall, if a claim thereof is to be made against the Corporation hereunder, notify the Corporation of the commencement thereof.  The failure to promptly notify the Corporation of the commencement of the proceeding, or Indemnitee’s request for indemnification, will not relieve the Corporation from any liability that it may have to Indemnitee hereunder, except to the extent the Corporation is prejudiced in its defense of such proceeding as a result of such failure.

 

(d)                                  In the event the Corporation shall be obligated to advance the expenses of Indemnitee with respect to a proceeding, as provided in this Agreement, the Corporation, if appropriate, shall be entitled to assume the defense of such proceeding, with counsel reasonably acceptable to Indemnitee, upon the delivery to Indemnitee of written notice of its election to do so.  After delivery of such notice,

 

3



 

approval of such counsel by Indemnitee and the retention of such counsel by the Corporation, the Corporation will not be liable to Indemnitee under this Agreement for any fees of counsel subsequently incurred by Indemnitee with respect to the same proceeding, provided that (1) Indemnitee shall have the right to employ Indemnitee’s own counsel in such proceeding at Indemnitee’s expense and (2) if (i) the employment of counsel by Indemnitee has been previously authorized in writing by the Corporation, (ii) counsel to the Corporation or Indemnitee shall have reasonably concluded that there may be a conflict of interest or position, or reasonably believes that a conflict is likely to arise, on any significant issue between the Corporation and Indemnitee in the conduct of any such defense or (iii) the Corporation shall not, in fact, have employed counsel to assume the defense of such proceeding, then the fees and expenses of Indemnitee’s counsel shall be at the expense of the Corporation, except as otherwise expressly provided by this Agreement.  The Corporation shall not be entitled, without the consent of Indemnitee, to assume the defense of any claim brought by or in the right of the Corporation or as to which counsel for the Corporation or Indemnitee shall have reasonably made the conclusion provided for in clause (ii) above.

 

4. Procedure for Indemnification

 

(a)                                  To obtain indemnification, Indemnitee shall promptly submit to the Corporation a written request, including therein or therewith such documentation and information as is reasonably available to Indemnitee and is reasonably necessary to determine whether and to what extent Indemnitee is entitled to indemnification. The Corporation shall, promptly upon receipt of such a request for indemnification, advise the Board of Directors in writing that Indemnitee has requested indemnification.

 

(b)                                  The Corporation’s determination whether to grant Indemnitee’s indemnification request shall be made promptly, and in any event within sixty (60) days following receipt of a request for indemnification pursuant to Section 4(a).

 

(c)                                   Notwithstanding the foregoing, (i) the obligations of the Corporation under Sections 1 and 2 shall be subject to the condition that the Reviewing Party (as defined below) shall not have determined (in a written opinion, in any case in which the independent legal counsel serves as the Reviewing Party) that applicable law prohibits the Corporation from indemnifying the Indemnitee, and (ii) the obligation of the Corporation to advance the expenses of Indemnitee pursuant to Section 3 shall be subject to the condition that, if, when and to the extent that the Reviewing Party determines that applicable law prohibits the Corporation from indemnifying the Indemnitee, the Corporation shall be entitled to be reimbursed by Indemnitee (who hereby agrees to reimburse the Corporation) for all such amounts advanced; provided, however, that if Indemnitee has commenced legal proceedings in a court of competent jurisdiction pursuant to Section 5 to secure a determination that Indemnitee should be indemnified under applicable law, any determination made by the Reviewing Party that applicable law prohibits indemnification shall not be binding and Indemnitee shall not be required to reimburse the Corporation for any advance of expenses until a final judicial determination is made with respect thereto (as to which all rights of appeal therefrom have been exhausted or have lapsed).  Indemnitee’s obligation to reimburse the Corporation for advances of expenses pursuant to this Section 4(c) shall be unsecured and no interest shall be charged thereon.  The Reviewing Party shall be selected by the Board, unless there has been a Change in Control, other than a Change in Control that has been approved by a majority of the Board who were directors immediately prior to such Change in Control, in which case the Reviewing Party shall be independent legal counsel.  “Reviewing Party” means any appropriate person or body consisting of either (x) a member or members of the Board who are not a party to the particular proceeding with respect to which Indemnitee is seeking indemnification or (y) independent legal counsel.

 

4



 

(d)                                  In connection with any determination by the Reviewing Party or otherwise as to whether the Indemnitee is entitled to be indemnified hereunder, the burden of proof shall be on the Corporation to establish that Indemnitee is not so entitled.

 

5. Enforcement of Indemnification Rights .  If the Reviewing Party determines that Indemnitee would not be permitted to be indemnified in whole or in part under applicable law, or if Indemnitee has not otherwise been paid in full pursuant to Section 2 within thirty (30) days, or pursuant to Section 3 within sixty (60) days, after a written demand has been received by the Corporation, Indemnitee shall have the right to commence litigation in any court in the State of Delaware having subject matter jurisdiction thereof and in which venue is proper to recover the unpaid amount of the demand (an “Enforcement Proceeding”) and, if successful in whole or in part, Indemnitee shall be entitled to be paid any and all expenses in connection with such Enforcement Proceeding.  The Corporation hereby consents to service of process for such Enforcement Proceeding and to appear in any such Enforcement Proceeding.  Any determination by the Reviewing Party otherwise shall be conclusive and binding on the Corporation and Indemnitee.

 

6. Insurance and Subrogation .

 

(a)                                  The Corporation may purchase and maintain insurance on behalf of any Indemnitee who is or was or has agreed to serve at the request of the Corporation as a director or officer of the Corporation, or is or was serving at the request of the Corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust, employee benefit plan or other enterprise against any liability asserted against, and incurred by, Indemnitee or on Indemnitee’s behalf in any such capacity, or arising out of Indemnitee’s status as such, whether or not the Corporation would have the power to indemnify Indemnitee against such liability under the provisions of this Agreement. If the Corporation has such insurance in effect at the time the Corporation receives from Indemnitee any notice of the commencement of a proceeding, the Corporation shall give prompt notice of the commencement of such proceeding to the insurers in accordance with the procedures set forth in the policy.  The Corporation shall thereafter take all necessary or desirable action to cause such insurers to pay, on behalf of the Indemnitee, all amounts payable as a result of such proceeding in accordance with the terms of such policy.

 

(b)                                  In the event of any payment by the Corporation under this Agreement, the Corporation shall be subrogated to the extent of such payment to all of the rights of recovery of Indemnitee with respect to any insurance policy, and Indemnitee shall execute all papers required and take all action necessary to secure such rights, including execution of such documents as are necessary to enable the Corporation to bring suit to enforce such rights in accordance with the terms of such insurance policy. The Corporation shall pay or reimburse all expenses actually and reasonably incurred by Indemnitee in connection with such subrogation.

 

(c)                                   The Corporation shall not be liable under this Agreement to make any payment of amounts otherwise indemnifiable hereunder (including, but not limited to, judgments, fines, ERISA excise taxes or penalties, and amounts paid in settlement) if and to the extent that Indemnitee has otherwise actually received such payment under this Agreement or any insurance policy, contract, agreement or otherwise.

 

7. Certain Definitions . For purposes of this Agreement, the following definitions shall apply:

 

(a)                                  The term “proceeding” shall be broadly construed and shall include, without limitation, the preparation, prosecution, defense, settlement, arbitration and appeal of, and the giving of testimony in, any threatened, pending or completed claim, action, suit, alternative dispute resolution

 

5



 

mechanism, investigation or proceeding, hearing, appeal, or any other proceeding, whether civil, criminal, administrative or investigative and/or any inquiry or investigation, whether conducted by the Corporation or any other party, that Indemnitee in good faith believes might lead to the institution of any such action.

 

(b)                                  The term “by reason of the fact that Indemnitee is or was a director, officer, employee or agent of the Corporation, or is or was serving or has agreed to serve at the request of the Corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust, employee benefit plan or other enterprise” shall be broadly construed and shall include, without limitation, any actual or alleged act or omission to act.

 

(c)                                   The term “expenses” shall be broadly and reasonably construed and shall include, without limitation, all direct and indirect costs of any type or nature whatsoever (including, without limitation, all attorneys’ fees and related disbursements, appeal bonds, other out-of-pocket costs and reasonable compensation for time spent by Indemnitee for which Indemnitee is not otherwise compensated by the Corporation or any third party, provided that the rate of compensation and estimated time involved is approved by the Board of Directors, which approval shall not be unreasonably withheld), actually and reasonably incurred by Indemnitee in connection with either the investigation, defense or appeal of, or being a witness or otherwise participating in, a proceeding or establishing or enforcing a right to indemnification or advancement of expenses under this Agreement, Section 145 of the DGCL or otherwise (or preparing for any of the foregoing).

 

(d)                                  The term “Corporation” shall include, without limitation and in addition to the resulting corporation, any constituent corporation (including any constituent of a constituent) absorbed in a consolidation or merger which, if its separate existence had continued, would have had power and authority to indemnify its directors, officers, and employees or agents, so that any person who is or was a director, officer, employee or agent of such constituent corporation, or is or was serving at the request of such constituent corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust, employee benefit plan or other enterprise, shall stand in the same position under the provisions of this Agreement with respect to the resulting or surviving corporation as he or she would have with respect to such constituent corporation if its separate existence had continued.

 

(e)                                   The term “serving at the request of the Corporation” shall include, without limitation, any service as a director, officer, employee or agent of the Corporation which imposes duties on, or involves services by, such director, officer, employee or agent with respect to an employee benefit plan, its participants or beneficiaries.

 

(f)                                    The term “independent legal counsel” shall mean an attorney or firm of attorneys who shall not have otherwise performed services for the Corporation or Indemnitee within the last five years (other than with respect to matters concerning the rights of Indemnitee under this Agreement or of other indemnitees under similar indemnity agreements).  Such independent legal counsel shall not include any person who, under the applicable standards of professional conduct then prevailing, would have a conflict of interest in representing either the Corporation or Indemnitee in an action to determine Indemnitee’s rights under this Agreement.

 

(g)                                   A “Change in Control” shall be deemed to have occurred if:

 

(i)                                      any “person” (as such term is used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder (the “Exchange Act”)), other than (a) a trustee or other fiduciary holding securities under an employee benefit plan of the

 

6



 

Corporation; (b) a corporation owned, directly or indirectly, by the stockholders of the Corporation in substantially the same proportions as their ownership of stock of the Corporation; or (c) any current beneficial stockholder or group, as defined by Rule 13d-5 of the Exchange Act, including the heirs, assigns and successors thereof, of beneficial ownership, within the meaning of Rule 13d-3 of the Exchange Act, of securities possessing more than 50% of the total combined voting power of the Corporation’s outstanding securities; hereafter becomes the “beneficial owner,” as defined in Rule 13d-3 of the Exchange Act, directly or indirectly, of securities of the Corporation representing 20% or more of the total combined voting power represented by the Corporation’s then outstanding Voting Securities (as defined below);

 

(ii)                                   during any period of two consecutive years, individuals who at the beginning of such period constitute the Board and any new director whose election by the Board or nomination for election by the Corporation’s stockholders was approved by a vote of at least two-thirds of the directors then in office who either were directors at the beginning of the period or whose election or nomination for election was previously so approved, cease for any reason to constitute a majority thereof; or

 

(iii)                                the stockholders of the Corporation approve a merger or consolidation of the Corporation with any other corporation, other than a merger or consolidation that would result in the Voting Securities of the Corporation outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into Voting Securities of the surviving entity) at least 80% of the total voting power represented by the Voting Securities of the Corporation or such surviving entity outstanding immediately after such merger or consolidation, or the stockholders of the Corporation approve a plan of complete liquidation of the Corporation or an agreement for the sale or disposition by the Corporation, in one transaction or a series of transactions, of all or substantially all of the Corporation’s assets.

 

(h)                                  The term “Voting Securities” shall mean any securities of the Corporation that vote generally in the election of directors.

 

8. Limitation on Indemnification and Advancement .  Notwithstanding any other provision herein to the contrary, the Corporation shall not be obligated pursuant to this Agreement:

 

(a)                                  Claims Initiated by Indemnitee . To indemnify or advance expenses to Indemnitee with respect to a proceeding (or part thereof) initiated by Indemnitee, except with respect to a proceeding brought to establish or enforce a right to indemnification (which shall be governed by the provisions of Section 8(b) of this Agreement), or unless such proceeding (or part thereof) was authorized or consented to by the Board of Directors of the Corporation.

 

(b)                                  Action for Indemnification . To indemnify or advance expenses to Indemnitee for any expenses incurred by Indemnitee with respect to any proceeding instituted by Indemnitee to enforce or interpret this Agreement, unless Indemnitee is successful in establishing Indemnitee’s right to indemnification in such proceeding, in whole or in part, or unless and to the extent that the court in such proceeding shall determine that, despite Indemnitee’s failure to establish his or her right to indemnification, Indemnitee is entitled to indemnity for such expenses; provided, however, that nothing in this Section 8(b) is intended to limit the Corporation’s obligation with respect to the advancement of expenses to Indemnitee in connection with any such proceeding instituted by Indemnitee to enforce or interpret this Agreement, as provided in Section 3 hereof.

 

(c)                                   Section 16 Violations . To indemnify Indemnitee on account of any proceeding with respect to which final judgment is rendered against Indemnitee for payment or an accounting of profits

 

7



 

arising from the purchase or sale by Indemnitee of securities in violation of Section 16(b) of the Exchange Act or any similar successor statute.

 

(d)                                  Non-compete and Non-disclosure .  To indemnify or advance expenses to Indemnitee in connection with proceedings or claims involving the enforcement of non-compete and/or non-disclosure agreements or the non-compete and/or non-disclosure provisions of employment, consulting or similar agreements the Indemnitee may be a party to with the Corporation or any subsidiary of the Corporation.

 

9.  Certain Settlement Provisions .  The Corporation shall have no obligation to indemnify Indemnitee under this Agreement for amounts paid in settlement of any proceeding without the Corporation’s prior written consent, which shall not be unreasonably withheld.  The Corporation shall not settle any proceeding in any manner that would impose any fine or other obligation on Indemnitee without Indemnitee’s prior written consent, which shall not be unreasonably withheld.

 

10. Savings Clause .  The invalidity or unenforceability of any provision hereof shall in no way affect the validity or enforceability of any other provision.  Without limiting the generality of the foregoing, this Agreement is intended to confer upon Indemnitee indemnification rights to the fullest extent permitted by applicable laws.  In the event any provision hereof conflicts with any applicable law, such provision shall be deemed modified, consistent with the aforementioned intent, to the extent necessary to resolve such conflict.

 

11. Contribution .  In order to provide for just and equitable contribution in circumstances in which the indemnification provided for herein is held by a court of competent jurisdiction to be unavailable to Indemnitee in whole or in part, it is agreed that, in such event, the Corporation shall, to the fullest extent permitted by law, contribute to the payment of Indemnitee’s expenses (including attorneys’ fees) and losses with respect to any proceeding in proportion to the relative benefits received by the Corporation, on the one hand, and Indemnitee, on the other hand, from the transaction from which such proceeding arose; provided, however, that the proportion determined on the basis of relative benefit may, to the extent necessary to conform to law, be further adjusted by reference to the relative fault of the Corporation, on the one hand, and Indemnitee, on the other hand, in connection with the events that resulted in such expenses or losses, as well as any other equitable considerations which the law may require to be considered.  The relative fault of the Corporation, on the one hand, and Indemnitee, on the other hand, shall be determined by reference to, among other things, the degree to which the Corporation’s and Indemnitee’s respective actions were motivated by intent to gain personal profit or advantage, the degree to which their liability is primary or secondary, and the degree to which their conduct is active or passive.  Notwithstanding the foregoing, such contribution shall not be required where such holding by the court is due to (i) the failure of Indemnitee to meet the standard of conduct set forth in Section 1 hereof, or (ii) any limitation on indemnification set forth in Section 6(c), 8 or 9 hereof.

 

12. Notices .  All notices, requests, demands and other communications under this Agreement shall be in writing and shall be deemed duly given (i) if delivered by hand, on the date of such receipt, (ii) if delivered by overnight courier, one business day after being sent, (iii) in the case of telecopy notice, when acknowledged as received, or (iv) if mailed by domestic certified or registered mail with postage prepaid, on the third business day after the date postmarked.  Addresses for notice to either party are as shown on the signature page of this Agreement, or as subsequently modified by written notice.

 

13. Subsequent Change in Law . If there is a change in Delaware law (whether by amendment to the DGCL or by judicial decision) after adoption of this Agreement to expand further the

 

8



 

indemnification or advancement of expenses permitted to directors or officers, Indemnitee shall be entitled to such expanded indemnification and advancement, and this Agreement shall be deemed to be amended (without further action) to such extent.

 

14. Nonexclusivity .  The provisions for indemnification and advancement of expenses set forth in this Agreement shall not be deemed exclusive of any other rights which Indemnitee may have under any provision of law, the Corporation’s Certificate of Incorporation or By-Laws, in any court in which a proceeding is brought, the vote of the Corporation’s stockholders or disinterested directors (or a committee thereof), other agreements or otherwise, and Indemnitee’s rights hereunder shall continue after Indemnitee has ceased acting as an agent of the Corporation and shall inure to the benefit of the heirs, executors and administrators of Indemnitee.  However, no amendment or alteration of the Corporation’s Certificate of Incorporation or By-Laws or any other agreement shall adversely affect the rights provided to Indemnitee under this Agreement

 

15. Enforcement .  The Corporation shall be precluded from asserting in any judicial proceeding that the procedures and presumptions of this Agreement are not valid, binding and enforceable. The Corporation agrees that its execution of this Agreement shall constitute a stipulation by which it shall be irrevocably bound in any court of competent jurisdiction in which a proceeding by Indemnitee for enforcement of his or her rights hereunder shall have been commenced, continued or appealed, that its obligations set forth in this Agreement are unique and special, and that failure of the Corporation to comply with the provisions of this Agreement will cause irreparable and irremediable injury to Indemnitee, for which a remedy at law will be inadequate. As a result, in addition to any other right or remedy Indemnitee may have at law or in equity with respect to breach of this Agreement, Indemnitee shall be entitled to injunctive or mandatory relief directing specific performance by the Corporation of its obligations under this Agreement.

 

16. Interpretation of Agreement .  It is understood that the parties hereto intend this Agreement to be interpreted and enforced so as to provide indemnification to Indemnitee to the fullest extent now or hereafter permitted by law.

 

17. Entire Agreement .  This Agreement and the documents expressly referred to herein constitute the entire agreement between the parties hereto with respect to the matters covered hereby, and any other prior or contemporaneous oral or written understandings or agreements with respect to the matters covered hereby are expressly superseded by this Agreement.

 

18. Modification and Waiver .  Except as provided in Section 13, no supplement, modification or amendment of this Agreement shall be binding unless executed in writing by both of the parties hereto.  No waiver of any of the provisions of this Agreement shall be deemed or shall constitute a waiver of any other provision hereof (whether or not similar) nor shall such waiver constitute a continuing waiver.

 

19. Successor and Assigns .  All of the terms and provisions of this Agreement shall be binding upon, shall inure to the benefit of and shall be enforceable by the parties hereto and their respective successors, assigns, including any direct or indirect successor by purchase, merger, consolidation or otherwise to all or substantially all of the business and/or assets of the Corporation, spouses, heirs and personal and legal representatives.  The Corporation shall require and cause any direct or indirect successor (whether by purchase, merger, consolidation or otherwise) to all or substantially all of the business or assets of the Corporation, by written agreement in form and substance reasonably satisfactory to Indemnitee, expressly to assume and agree to perform this Agreement in the same manner and to the same extent that the Corporation would be required to perform if no such succession had taken place.  This Agreement shall continue in effect regardless of whether Indemnitee continues to serve as a director or officer of the Corporation or of any other enterprise at the Corporation’s request.

 

9



 

20. Service of Process and Venue .  For purposes of any claims or proceedings to enforce this agreement, the Corporation and Indemnitee consent to the jurisdiction and venue of any federal or state court of competent jurisdiction in the state of Delaware, and waive and agree not to raise any defense that any such court is an inconvenient forum or any similar claim.

 

21. Governing Law .  This Agreement shall be governed exclusively by and construed according to the laws of the State of Delaware, as applied to contracts between Delaware residents entered into and to be performed entirely within Delaware.

 

22. Employment Rights . Nothing in this Agreement is intended to create in Indemnitee any right to employment or continued employment.

 

23. Counterparts . This Agreement may be executed in two or more counterparts, each of which shall be deemed to be an original and all of which together shall be deemed to be one and the same instrument, notwithstanding that both parties are not signatories to the original or same counterpart.

 

24.  Headings . The section and subsection headings contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement.

 

IN WITNESS WHEREOF, this Agreement has been duly executed and delivered to be effective as of the date first above written.

 

VEECO INSTRUMENTS INC.

 

INDEMNITEE:

 

 

 

 

 

 

By:

 

 

 

Name:

 

 

Name:

 

Title:

 

 

 

 

 

 

 

 

 

Address:

Terminal Drive

 

Address:

 

 

Plainview, NY 11803

 

 

 

 

U.S.A.

 

 

 

Telecopy:

516-677-0380

 

Telecopy:

 

 

10


Exhibit 31.1

 

CERTIFICATION PURSUANT TO
RULE 13a — 14(a) or RULE 15d — 14(a)
OF THE SECURITIES EXCHANGE ACT OF 1934

 

I, John R. Peeler, certify that:

 

1.               I have reviewed this quarterly report on Form 10-Q for the period ended June 30, 2017 of Veeco Instruments Inc.;

 

2.               Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.               Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.               The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)          designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)          designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)           evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)          disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.               The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)          all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)          any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

 

 

 

/s/ JOHN R. PEELER

 

 

By:

John R. Peeler

 

 

 

Chairman and Chief Executive Officer

 

 

 

Veeco Instruments Inc.

 

 

 

August 3, 2017

 

1


Exhibit 31.2

 

CERTIFICATION PURSUANT TO
RULE 13a — 14(a) or RULE 15d — 14(a)
OF THE SECURITIES EXCHANGE ACT OF 1934

 

I, Shubham Maheshwari, certify that:

 

1.               I have reviewed this quarterly report on Form 10-Q for the period ended  June 30, 2017 of Veeco Instruments Inc.;

 

2.               Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.               Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.               The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)          designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)          designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)           evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)          disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.               The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)          all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)          any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

 

 

 

/s/ SHUBHAM MAHESHWARI

 

 

By:

Shubham Maheshwari

 

 

 

Executive Vice President and Chief Financial Officer

 

 

 

Veeco Instruments Inc.

 

 

 

August 3, 2017

 

1


Exhibit 32.1

 

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the quarterly report of Veeco Instruments Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2017 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, John R. Peeler, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1)          The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)          The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

 

 

/s/ JOHN R. PEELER

 

 

By:

John R. Peeler

 

 

 

Chairman and Chief Executive Officer

 

 

 

Veeco Instruments Inc.

 

 

 

August 3, 2017

 

A signed original of this written statement required by Section 906 has been provided to Veeco Instruments Inc. and will be retained by Veeco Instruments Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

 

1


Exhibit 32.2

 

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the quarterly report of Veeco Instruments Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2017 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Shubham Maheshwari, Executive Vice President and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1)          The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)          The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

 

 

/s/ SHUBHAM MAHESHWARI

 

 

By:

Shubham Maheshwari

 

 

 

Executive Vice President and Chief Financial Officer

 

 

 

Veeco Instruments Inc.

 

 

 

August 3, 2017

 

A signed original of this written statement required by Section 906 has been provided to Veeco Instruments Inc. and will be retained by Veeco Instruments Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

 

1